data_6b5w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6b5w _Structure_validation_residue.Date_analyzed 2017-10-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.475 0 N-CA-C 116.181 1.232 . . . . 0.0 116.181 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.46 100.02 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.69 1.996 . . . . 0.0 109.243 -170.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.87 -161.34 53.93 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.56 172.9 7.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.441 1.496 . . . . 0.0 112.563 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.34 -63.81 0.58 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 118.851 0.75 . . . . 0.0 114.086 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -134.28 174.31 4.81 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 129.471 3.108 . . . . 0.0 111.205 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -66.0 147.98 85.2 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 CA-C-N 124.023 2.473 . . . . 0.0 114.023 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -70.94 134.18 47.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.683 -1.261 . . . . 0.0 108.783 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.5 m -75.52 -39.67 58.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 119.834 -1.791 . . . . 0.0 114.992 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 mt -83.92 -71.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.082 1.753 . . . . 0.0 110.989 -172.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -138.71 143.97 39.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 122.312 1.053 . . . . 0.0 110.432 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.5 70.18 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.039 2.535 . . . . 0.0 114.118 -171.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.36 154.29 38.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 132.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.31 -42.75 92.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.638 -2.538 . . . . 0.0 113.303 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -135.73 169.06 18.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.425 1.49 . . . . 0.0 114.525 -175.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.37 156.8 32.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 130.105 3.362 . . . . 0.0 111.622 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -69.83 157.58 89.33 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 125.931 1.692 . . . . 0.0 113.073 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.448 -1.151 1 C-N-CA 126.465 4.777 . . . . 0.0 110.381 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 CA-C-O 121.734 0.63 . . . . 0.0 111.675 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.92 118.89 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.336 1.454 . . . . 0.0 110.366 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.1 -162.38 51.57 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 119.878 1.217 . . . . 0.0 111.562 -170.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -131.57 168.31 17.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 119.525 -2.162 . . . . 0.0 111.009 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.57 -77.43 0.31 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 127.163 2.316 . . . . 0.0 113.658 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.64 161.02 43.95 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.301 1.84 . . . . 0.0 114.798 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.03 119.48 6.71 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 CA-C-N 120.634 1.262 . . . . 0.0 113.34 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -54.07 117.64 3.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.261 2.224 . . . . 0.0 109.254 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -62.63 -9.6 9.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.2 mt -137.48 -64.06 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.917 1.687 . . . . 0.0 111.142 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.5 mt -92.9 160.92 14.69 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.335 1.454 . . . . 0.0 113.815 -167.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -83.14 72.48 10.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.819 1.248 . . . . 0.0 113.7 -165.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -144.41 159.09 43.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.029 0.919 . . . . 0.0 111.395 167.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.47 -32.61 72.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 116.754 -1.593 . . . . 0.0 114.732 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -140.06 156.33 46.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.91 158.88 44.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.317 3.047 . . . . 0.0 111.581 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -96.9 140.97 22.41 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 127.941 2.497 . . . . 0.0 110.561 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.448 -1.16 0 C-N-CA 122.322 2.015 . . . . 0.0 113.36 -179.37 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.767 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.0 p -148.15 155.9 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.137 2.175 . . . . 0.0 107.108 161.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 54.06 -139.39 37.26 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 121.636 2.016 . . . . 0.0 113.582 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.99 146.8 49.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.727 1.611 . . . . 0.0 113.618 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.43 -78.54 0.08 OUTLIER Glycine 0 C--N 1.335 0.497 0 N-CA-C 116.906 1.523 . . . . 0.0 116.906 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -145.68 172.67 5.03 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 129.633 3.173 . . . . 0.0 111.782 -168.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.08 100.68 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.309 2.006 . . . . 0.0 111.216 169.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -81.04 74.66 8.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.357 1.463 . . . . 0.0 110.329 173.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -56.5 -7.72 0.44 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -159.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.0 mt -52.57 -46.05 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 127.395 2.278 . . . . 0.0 111.531 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tt -134.79 139.48 45.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.357 1.863 . . . . 0.0 110.216 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -72.49 80.19 1.06 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.457 1.103 . . . . 0.0 111.317 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -137.54 165.48 26.2 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.614 1.166 . . . . 0.0 110.436 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.04 155.23 40.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.469 1.108 . . . . 0.0 112.668 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 29.21 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.16 3.784 . . . . 0.0 113.42 147.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.25 146.63 46.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.59 2.356 . . . . 0.0 110.315 -177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -59.96 155.41 43.28 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 126.7 2.0 . . . . 0.0 112.421 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo . . . . . 0 N--CA 1.45 -1.088 0 C-N-CA 123.154 2.57 . . . . 0.0 112.512 157.41 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.504 0 CA-C-O 117.512 -1.715 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -152.59 152.49 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.848 2.059 . . . . 0.0 109.415 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.57 -160.99 43.36 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 119.183 0.901 . . . . 0.0 114.312 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.71 164.28 28.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.594 -1.533 . . . . 0.0 114.719 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.72 -154.76 19.34 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 124.735 1.159 . . . . 0.0 111.306 -158.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -50.51 150.32 4.89 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 126.876 2.07 . . . . 0.0 113.076 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.65 145.06 96.96 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.864 3.043 . . . . 0.0 113.788 -168.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -68.6 139.29 55.53 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.626 -1.296 . . . . 0.0 109.489 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -71.77 -79.36 0.07 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -75.03 -74.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.609 1.164 . . . . 0.0 112.015 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 tp -60.06 117.99 5.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.862 -1.774 . . . . 0.0 109.053 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -69.3 71.9 0.29 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.522 1.529 . . . . 0.0 112.984 -171.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -108.52 135.48 49.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.784 1.634 . . . . 0.0 107.705 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -56.16 -38.14 70.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.506 -1.371 . . . . 0.0 113.359 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -131.43 153.52 49.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.297 1.439 . . . . 0.0 108.508 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.82 153.15 42.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.471 1.908 . . . . 0.0 113.324 172.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -61.93 141.91 95.32 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.851 169.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 N--CA 1.449 -1.094 0 C-N-CA 123.286 2.658 . . . . 0.0 110.085 177.609 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.47 112.26 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.237 2.215 . . . . 0.0 108.233 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.6 -163.38 27.27 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 126.6 2.048 . . . . 0.0 114.97 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -117.01 155.1 29.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.523 1.129 . . . . 0.0 112.106 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.437 ' H ' ' NE2' ' A' ' 15' ' ' GLN . . . 128.04 -137.18 9.59 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 127.187 2.327 . . . . 0.0 114.202 -169.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -63.1 150.89 87.64 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 128.071 2.549 . . . . 0.0 111.996 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -62.62 147.94 94.06 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.862 3.041 . . . . 0.0 112.985 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -96.82 87.01 4.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.231 -1.35 . . . . 0.0 113.052 -162.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -50.74 -30.22 13.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.2 mt -68.69 -26.51 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.425 1.49 . . . . 0.0 110.04 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.77 -152.03 0.49 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.135 2.174 . . . . 0.0 108.169 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -130.48 89.83 2.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.508 -1.37 . . . . 0.0 110.694 160.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -138.26 155.28 48.77 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.29 1.836 . . . . 0.0 110.361 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -56.58 -38.62 72.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.479 1.112 . . . . 0.0 113.782 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.437 ' NE2' ' H ' ' A' ' 5' ' ' GLY . 36.5 mt-30 -141.63 153.56 44.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.43 154.81 40.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.724 3.21 . . . . 0.0 110.802 157.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -76.06 151.49 83.98 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 116.662 -1.637 . . . . 0.0 108.454 159.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.448 -1.15 0 C-N-CA 123.078 2.519 . . . . 0.0 109.103 167.517 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 112.936 -0.065 . . . . 0.0 112.936 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 p -149.4 95.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.996 2.118 . . . . 0.0 113.603 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.07 -124.11 19.36 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 124.984 1.278 . . . . 0.0 112.034 -174.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.96 163.55 39.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.967 1.707 . . . . 0.0 114.023 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.37 -52.19 0.49 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 128.005 2.716 . . . . 0.0 113.114 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -139.88 175.39 3.23 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 131.421 3.888 . . . . 0.0 109.626 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.79 163.71 38.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 CA-C-N 124.869 2.775 . . . . 0.0 112.896 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -78.3 99.98 6.53 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 171.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 m -65.12 -15.36 62.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.49 -46.0 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.403 1.081 . . . . 0.0 112.616 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 tt -153.64 114.77 4.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.797 2.039 . . . . 0.0 109.707 173.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -63.9 109.2 1.69 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.002 0.921 . . . . 0.0 112.03 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -134.0 -81.46 0.46 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 165.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -123.13 -174.46 2.95 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.739 2.416 . . . . 0.0 111.146 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -66.28 166.07 12.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.45 178.95 9.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.494 2.718 . . . . 0.0 111.921 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -105.32 170.01 6.42 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 126.944 2.098 . . . . 0.0 111.6 161.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.449 -1.124 0 C-N-CA 122.967 2.445 . . . . 0.0 111.973 167.494 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 117.524 -1.709 . . . . 0.0 114.298 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 p -116.93 129.3 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 120.239 2.019 . . . . 0.0 110.453 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.87 -155.75 39.33 Favored Glycine 0 C--N 1.335 0.52 0 O-C-N 120.799 -1.188 . . . . 0.0 113.214 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.269 0.3 OUTLIER -134.38 165.53 24.93 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 120.369 -1.665 . . . . 0.0 113.638 175.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.37 -153.19 17.59 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 126.166 1.841 . . . . 0.0 110.961 -159.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.22 148.46 3.16 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 127.205 2.202 . . . . 0.0 114.703 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.77 149.05 72.63 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.854 3.036 . . . . 0.0 111.986 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -93.05 160.31 14.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 119.517 -1.989 . . . . 0.0 113.839 -160.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.0 m -97.95 -32.2 11.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -161.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -116.53 -69.25 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.215 1.406 . . . . 0.0 110.187 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.88 119.65 12.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.849 1.259 . . . . 0.0 109.842 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.9 m -47.91 108.53 0.17 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.633 1.573 . . . . 0.0 112.073 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -156.48 144.38 19.47 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.638 -1.289 . . . . 0.0 113.855 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.44 -31.89 73.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 165.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -144.12 149.69 36.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 125.192 1.558 . . . . 0.0 113.882 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.7 161.78 34.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.086 2.555 . . . . 0.0 112.138 171.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 7.1 mmpt? -58.33 145.91 73.3 Favored Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 120.524 -1.36 . . . . 0.0 113.186 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 N--CA 1.45 -1.076 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 160.168 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.15 141.1 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 120.458 2.129 . . . . 0.0 111.325 159.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.22 -165.4 54.61 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 119.147 0.885 . . . . 0.0 112.981 -165.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -136.16 142.43 44.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.299 -1.118 . . . . 0.0 111.601 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.9 -113.16 0.55 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 126.156 1.836 . . . . 0.0 110.663 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.9 ptt85 -64.9 168.84 6.33 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 120.687 2.244 . . . . 0.0 112.719 168.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.82 161.38 39.5 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 CA-C-N 120.725 1.295 . . . . 0.0 113.523 163.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.62 158.78 30.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 119.42 -2.05 . . . . 0.0 112.029 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.8 m -83.94 -28.03 28.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.874 2.47 . . . . 0.0 114.377 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.7 mt -107.54 -79.95 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.564 1.546 . . . . 0.0 111.107 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.96 137.95 16.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.274 1.829 . . . . 0.0 109.701 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.283 12.4 t -71.61 74.44 0.8 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.235 1.014 . . . . 0.0 109.576 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -139.52 150.29 44.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 119.377 -2.077 . . . . 0.0 112.257 -166.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -86.37 -18.36 32.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.113 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -129.3 116.53 19.25 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.181 1.392 . . . . 0.0 112.872 -166.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.84 127.82 15.52 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.567 2.347 . . . . 0.0 109.659 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -77.43 124.88 86.82 Favored Pre-proline 0 N--CA 1.449 -0.505 0 O-C-N 119.281 -2.137 . . . . 0.0 108.269 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 0 N--CA 1.449 -1.129 0 C-N-CA 123.469 2.78 . . . . 0.0 115.802 -173.249 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 CA-C-O 119.534 -0.592 . . . . 0.0 112.84 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.61 65.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.741 1.216 . . . . 0.0 110.441 -162.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.99 177.86 37.05 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 127.895 2.664 . . . . 0.0 114.927 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -64.22 141.73 58.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 119.969 -1.901 . . . . 0.0 115.015 -169.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.93 -144.02 11.28 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.391 1.472 . . . . 0.0 112.792 -173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 164.88 12.82 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 125.765 1.626 . . . . 0.0 113.696 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -60.45 135.77 63.36 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 CA-C-N 122.759 2.021 . . . . 0.0 111.509 166.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -88.21 93.09 9.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.879 0.847 . . . . 0.0 110.886 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -67.81 -22.69 65.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.3 mt -79.66 -49.41 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.28 1.032 . . . . 0.0 112.931 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.4 116.5 16.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.824 1.649 . . . . 0.0 108.097 -174.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.8 m -48.78 95.63 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.577 2.351 . . . . 0.0 115.576 -166.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -150.83 163.85 37.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 129.367 3.067 . . . . 0.0 109.363 160.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.03 10.87 10.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.544 -1.348 . . . . 0.0 114.574 166.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -144.72 122.95 12.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.378 1.871 . . . . 0.0 114.175 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.43 133.43 25.83 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.907 2.883 . . . . 0.0 112.068 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -46.2 115.64 3.14 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 126.472 1.909 . . . . 0.0 110.577 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.449 -1.123 0 C-N-CA 124.418 3.412 . . . . 0.0 111.278 -166.363 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 117.623 1.809 . . . . 0.0 117.623 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.53 169.73 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 126.984 2.114 . . . . 0.0 108.36 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.84 -143.54 45.17 Favored Glycine 0 CA--C 1.522 0.511 0 O-C-N 119.61 -1.932 . . . . 0.0 113.594 161.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.7 161.05 38.9 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.414 1.086 . . . . 0.0 113.417 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.14 -78.18 0.21 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 126.469 1.985 . . . . 0.0 112.97 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.71 167.14 23.41 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 130.253 3.421 . . . . 0.0 114.025 -167.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -70.73 113.09 3.42 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 CA-C-N 122.908 2.074 . . . . 0.0 115.523 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -68.63 105.39 2.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.371 1.468 . . . . 0.0 110.448 163.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -58.04 -19.11 28.95 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 117.678 2.473 . . . . 0.0 117.678 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.9 mm -94.98 -16.74 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.574 1.95 . . . . 0.0 108.821 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.2 tp -146.63 93.45 2.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 119.825 -1.797 . . . . 0.0 112.028 -168.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.0 p -64.23 16.25 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 119.563 3.172 . . . . 0.0 119.563 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -52.98 104.87 0.1 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.025 0.93 . . . . 0.0 111.361 159.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.4 138.17 56.49 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 124.149 0.906 . . . . 0.0 111.518 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.49 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.503 1.921 . . . . 0.0 112.223 -157.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.1 -170.14 2.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.258 1.823 . . . . 0.0 111.667 170.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -148.27 135.74 10.73 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 126.85 2.06 . . . . 0.0 108.342 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 N--CA 1.449 -1.14 0 C-N-CA 122.373 2.049 . . . . 0.0 110.195 171.416 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.527 0 CA-C-O 118.184 -1.342 . . . . 0.0 112.839 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.46 114.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 128.996 2.919 . . . . 0.0 110.841 168.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.11 -153.16 52.86 Favored Glycine 0 N--CA 1.448 -0.546 0 O-C-N 121.098 -1.001 . . . . 0.0 111.84 -170.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.03 166.92 23.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.83 -87.91 0.2 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 125.769 1.652 . . . . 0.0 110.804 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -76.42 168.27 29.49 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 124.889 1.275 . . . . 0.0 109.816 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -67.93 151.66 77.78 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 CA-C-N 121.379 1.528 . . . . 0.0 112.828 161.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -82.41 122.53 28.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.037 -1.039 . . . . 0.0 110.211 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 m -59.19 -12.37 5.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mt -120.23 140.26 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.55 98.22 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.96 1.704 . . . . 0.0 110.293 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -151.29 -67.48 0.18 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.417 -0.802 . . . . 0.0 110.061 -168.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -142.54 162.22 36.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.323 2.649 . . . . 0.0 109.214 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -54.7 -35.83 64.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.583 1.553 . . . . 0.0 114.454 -168.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -136.25 174.55 10.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.096 2.159 . . . . 0.0 111.811 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.66 162.09 39.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.195 -1.566 . . . . 0.0 109.863 167.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -66.71 172.52 3.23 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.231 1.012 . . . . 0.0 111.354 163.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.45 -1.073 0 C-N-CA 124.715 3.61 . . . . 0.0 114.994 157.518 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.52 0 N-CA-C 118.052 1.981 . . . . 0.0 118.052 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.5 137.18 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.77 2.028 . . . . 0.0 110.971 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.34 -150.92 20.7 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.072 1.32 . . . . 0.0 116.162 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -145.36 151.47 38.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 119.478 1.639 . . . . 0.0 113.418 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.72 -114.69 0.8 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 126.779 2.133 . . . . 0.0 109.894 -165.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 160.72 78.09 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 127.861 2.464 . . . . 0.0 113.514 172.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.67 138.17 62.81 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 CA-C-N 121.057 1.413 . . . . 0.0 111.691 151.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.7 164.83 25.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.416 0.686 . . . . 0.0 111.871 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.8 m -77.32 -57.51 3.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.688 -0.633 . . . . 0.0 111.668 -169.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.8 mt -94.72 -63.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -166.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.23 130.34 42.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.178 1.391 . . . . 0.0 109.178 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.9 t -69.05 21.65 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -63.04 132.31 51.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.113 2.165 . . . . 0.0 111.346 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -62.14 -15.84 48.59 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.476 -1.726 . . . . 0.0 113.398 168.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.0 120.55 16.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 121.515 1.961 . . . . 0.0 113.186 -172.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.37 153.8 41.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.123 2.169 . . . . 0.0 113.644 162.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -72.42 134.1 82.57 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-O 117.385 -1.293 . . . . 0.0 111.856 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 N--CA 1.45 -1.072 0 C-N-CA 122.573 2.182 . . . . 0.0 110.08 175.905 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.439 0 CA-C-O 117.433 -1.76 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.34 6.3 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 119.093 1.447 . . . . 0.0 114.585 -170.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.71 -155.38 25.34 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 125.811 1.672 . . . . 0.0 109.486 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.96 150.56 39.04 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 120.694 2.247 . . . . 0.0 114.92 171.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.66 -125.35 2.97 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.999 1.761 . . . . 0.0 115.532 -170.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.53 164.97 4.59 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 128.216 2.606 . . . . 0.0 113.929 171.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.49 155.34 59.76 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.833 3.689 . . . . 0.0 110.511 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.72 136.85 56.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.838 -1.164 . . . . 0.0 112.381 -173.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.2 p -64.48 -31.28 72.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.876 1.671 . . . . 0.0 115.026 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.5 pt -132.23 -13.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.1 mt -105.9 159.08 16.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.589 -1.319 . . . . 0.0 110.676 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -82.9 65.11 7.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.562 -1.336 . . . . 0.0 109.455 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -137.34 159.84 40.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.393 1.477 . . . . 0.0 110.567 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -105.65 -9.44 17.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.565 1.166 . . . . 0.0 111.623 -166.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -128.17 118.23 23.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.724 1.147 . . . . 0.0 112.054 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.0 150.79 37.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 129.096 2.958 . . . . 0.0 112.308 164.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HE2' ' HD2' ' A' ' 18' ' ' PRO . 3.0 mmpt? -74.42 171.88 10.17 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 120.61 -1.306 . . . . 0.0 110.909 163.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 59.0 Cg_endo . . . . . 0 N--CA 1.449 -1.138 0 CA-C-N 120.766 1.309 . . . . 0.0 111.275 150.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 CA-C-O 118.687 -1.063 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.23 116.09 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 126.515 1.926 . . . . 0.0 110.824 -177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.83 -146.03 24.01 Favored Glycine 0 CA--C 1.523 0.546 0 O-C-N 119.918 -1.738 . . . . 0.0 113.095 -168.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -145.28 166.73 24.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.516 1.526 . . . . 0.0 110.145 174.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.99 -86.67 0.23 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.942 1.258 . . . . 0.0 115.075 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -122.39 173.52 4.11 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 127.683 2.393 . . . . 0.0 111.52 -174.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -48.97 154.07 3.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 124.042 3.162 . . . . 0.0 117.625 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -107.87 128.58 54.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.571 1.548 . . . . 0.0 109.358 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 p -69.89 -52.25 26.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -171.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.7 mt -99.29 -65.5 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.532 0.733 . . . . 0.0 110.056 -173.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.61 118.9 7.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.604 -1.31 . . . . 0.0 113.788 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -72.68 77.72 1.1 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.626 2.371 . . . . 0.0 110.873 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.44 172.88 12.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.38 2.272 . . . . 0.0 108.12 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -59.08 -67.6 0.35 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.429 1.491 . . . . 0.0 113.627 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -136.7 170.66 15.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.068 2.147 . . . . 0.0 111.125 -172.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.36 171.12 14.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 129.99 3.316 . . . . 0.0 109.012 167.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -66.28 167.01 13.74 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 120.99 -1.069 . . . . 0.0 108.896 159.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo . . . . . 0 N--CA 1.449 -1.12 0 CA-C-N 121.554 1.591 . . . . 0.0 111.072 158.075 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 119.251 -0.75 . . . . 0.0 114.687 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.93 140.54 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 118.194 0.997 . . . . 0.0 109.997 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.98 -164.66 53.1 Favored Glycine 0 CA--C 1.523 0.55 0 O-C-N 120.595 -1.316 . . . . 0.0 113.445 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -142.15 165.31 27.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.521 -0.987 . . . . 0.0 112.413 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.48 -26.74 3.31 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 128.562 2.982 . . . . 0.0 114.196 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -150.51 174.53 3.44 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 127.035 2.134 . . . . 0.0 110.546 -173.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.15 159.29 50.22 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.712 2.275 . . . . 0.0 111.161 169.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -84.56 154.47 22.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.952 1.701 . . . . 0.0 112.684 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.1 p -124.4 -2.78 7.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.861 2.064 . . . . 0.0 114.908 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.2 mt -123.72 -43.12 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.846 2.058 . . . . 0.0 110.16 -170.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.8 mt -112.33 154.07 26.26 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.595 1.158 . . . . 0.0 111.201 169.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.1 m -69.96 87.1 0.54 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.28 1.032 . . . . 0.0 108.866 172.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -143.03 152.52 41.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.465 1.106 . . . . 0.0 110.931 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -79.62 -11.19 59.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -133.38 134.54 43.84 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.096 2.158 . . . . 0.0 111.707 -170.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.19 163.13 36.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.478 1.111 . . . . 0.0 110.699 155.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -87.83 145.58 37.06 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 127.326 2.251 . . . . 0.0 110.198 155.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.449 -1.143 0 CA-C-N 121.443 1.551 . . . . 0.0 111.423 168.239 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.507 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.03 133.43 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 118.25 1.025 . . . . 0.0 111.216 163.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.72 -159.71 7.09 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 125.195 1.378 . . . . 0.0 115.584 -170.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -141.28 169.73 17.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.219 1.408 . . . . 0.0 113.006 173.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.23 -154.92 16.66 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 128.086 2.755 . . . . 0.0 111.629 -154.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -34.42 138.57 0.32 Allowed Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 128.3 2.64 . . . . 0.0 115.789 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.6 146.4 43.65 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.117 2.545 . . . . 0.0 115.664 -170.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -68.51 133.41 48.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.789 1.236 . . . . 0.0 111.333 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 m -118.41 16.09 13.85 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.407 1.483 . . . . 0.0 113.856 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.1 mt -118.31 -63.21 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 128.565 2.746 . . . . 0.0 108.16 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -87.27 166.63 14.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.279 1.832 . . . . 0.0 109.432 173.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -77.98 82.37 4.34 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.204 1.401 . . . . 0.0 110.586 161.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -142.41 144.04 32.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.794 1.238 . . . . 0.0 112.629 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.42 -6.82 59.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -146.25 137.87 24.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.544 -1.217 . . . . 0.0 109.731 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.03 165.67 33.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.461 1.504 . . . . 0.0 113.652 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -59.95 134.66 90.05 Favored Pre-proline 0 N--CA 1.449 -0.524 0 O-C-N 119.719 -1.863 . . . . 0.0 111.193 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 N--CA 1.45 -1.056 0 C-N-CA 122.574 2.183 . . . . 0.0 109.839 168.065 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.55 0 CA-C-O 122.344 0.969 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.21 136.26 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 O-C-N 119.655 -2.085 . . . . 0.0 112.554 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.11 -154.27 27.53 Favored Glycine 0 CA--C 1.522 0.504 0 O-C-N 120.54 -1.35 . . . . 0.0 114.735 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -145.59 168.66 20.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.173 -0.604 . . . . 0.0 110.929 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.18 -19.45 17.55 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 118.177 2.031 . . . . 0.0 118.177 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -139.48 171.09 8.54 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 126.978 2.111 . . . . 0.0 108.143 171.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.39 152.84 75.15 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 CA-C-N 122.768 2.024 . . . . 0.0 113.288 168.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -71.93 162.11 29.95 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.034 -1.666 . . . . 0.0 112.479 165.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -103.33 -21.22 13.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.221 2.208 . . . . 0.0 115.769 170.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.7 mt -135.77 118.67 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.845 1.658 . . . . 0.0 109.312 -159.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.4 tp 70.26 142.27 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 129.67 3.188 . . . . 0.0 111.77 -170.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 m -60.85 88.87 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.619 1.168 . . . . 0.0 112.212 171.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -134.66 171.82 13.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.726 2.411 . . . . 0.0 110.956 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -78.65 -158.17 0.13 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 118.204 -2.81 . . . . 0.0 111.185 170.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -48.83 158.82 0.29 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.738 2.415 . . . . 0.0 115.772 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.65 -178.53 5.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.765 2.826 . . . . 0.0 112.466 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -135.85 151.42 74.01 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 130.22 3.408 . . . . 0.0 108.623 168.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.449 -1.136 0 C-N-CA 122.079 1.853 . . . . 0.0 113.19 170.649 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.539 0 CA-C-O 122.056 0.809 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.61 80.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.169 2.588 . . . . 0.0 109.892 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 113.26 -135.92 13.0 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 127.689 2.566 . . . . 0.0 114.682 168.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -144.99 149.42 35.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.374 1.087 . . . . 0.0 109.615 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.75 -62.14 0.48 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 125.262 1.411 . . . . 0.0 114.565 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.98 156.71 68.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 112.424 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.43 136.53 74.97 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.162 1.908 . . . . 0.0 111.952 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -64.13 146.87 53.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.735 2.014 . . . . 0.0 110.597 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.2 m -112.02 -10.09 13.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 mt -73.49 -60.95 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 119.997 1.271 . . . . 0.0 110.776 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.6 mt -125.94 171.06 11.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.368 1.467 . . . . 0.0 111.103 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -74.87 83.5 2.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.464 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -124.45 123.1 39.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.281 1.832 . . . . 0.0 108.656 166.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -57.18 -21.92 36.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.78 1.632 . . . . 0.0 113.164 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -132.99 118.16 18.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.787 2.035 . . . . 0.0 110.23 -163.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.81 154.73 40.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.461 2.305 . . . . 0.0 110.311 168.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -66.41 158.25 78.88 Favored Pre-proline 0 N--CA 1.45 -0.451 0 O-C-N 120.897 -1.127 . . . . 0.0 111.897 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 N--CA 1.45 -1.045 0 C-N-CA 122.413 2.076 . . . . 0.0 110.367 145.213 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.491 0 N-CA-C 117.856 1.902 . . . . 0.0 117.856 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.5 p -141.03 135.97 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 120.778 -1.425 . . . . 0.0 112.529 174.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 61.02 -110.6 3.16 Favored Glycine 0 CA--C 1.522 0.5 0 O-C-N 120.095 -1.628 . . . . 0.0 115.544 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -136.39 150.79 48.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.153 2.181 . . . . 0.0 113.153 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.36 -145.2 13.39 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.526 1.536 . . . . 0.0 115.116 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.68 175.76 0.3 Allowed Pre-proline 0 N--CA 1.449 -0.486 1 C-N-CA 132.692 4.397 . . . . 0.0 115.143 173.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.02 106.67 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.232 3.288 . . . . 0.0 113.464 165.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -74.21 101.8 4.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.798 1.239 . . . . 0.0 109.751 174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 m -76.78 28.57 0.13 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.383 2.673 . . . . 0.0 113.865 -168.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.66 -60.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.697 2.399 . . . . 0.0 108.163 168.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.59 89.69 3.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.414 1.486 . . . . 0.0 109.796 170.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -81.67 67.97 7.84 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.56 1.144 . . . . 0.0 112.359 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -77.94 66.32 3.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 123.863 1.792 . . . . 0.0 112.071 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 46.59 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.346 3.059 . . . . 0.0 113.75 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -100.04 117.89 35.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.27 146.47 29.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.786 1.279 . . . . 0.0 113.378 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -75.92 147.11 80.26 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 128.392 2.677 . . . . 0.0 110.601 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo . . . . . 0 N--CA 1.45 -1.075 0 C-N-CA 121.653 1.569 . . . . 0.0 112.335 175.343 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.07 152.88 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.38 1.872 . . . . 0.0 110.027 150.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.1 -137.49 31.67 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 119.957 1.253 . . . . 0.0 113.489 173.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -140.47 146.09 37.77 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.346 1.858 . . . . 0.0 114.32 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.8 -86.49 0.14 Allowed Glycine 0 C--N 1.336 0.547 0 O-C-N 121.467 -0.771 . . . . 0.0 114.043 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 161.59 45.4 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 128.595 2.758 . . . . 0.0 112.542 -172.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.96 124.46 13.57 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 CA-C-N 122.514 1.933 . . . . 0.0 110.911 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -58.23 114.62 2.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.151 1.381 . . . . 0.0 113.781 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.0 m -63.01 -24.88 68.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.2 mt -85.21 -55.17 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 119.711 1.141 . . . . 0.0 108.709 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -138.09 112.62 8.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 116.831 -1.557 . . . . 0.0 108.412 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -65.0 77.03 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -162.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -75.48 139.51 42.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 112.693 -2.049 . . . . 0.0 112.649 159.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -70.24 121.68 18.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.85 0.833 . . . . 0.0 111.845 170.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 59.06 104.47 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.689 2.396 . . . . 0.0 115.782 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.15 146.41 42.74 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 129.334 3.054 . . . . 0.0 111.519 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -63.24 113.87 10.91 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 127.846 2.459 . . . . 0.0 110.179 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo . . . . . 0 N--CA 1.448 -1.151 0 C-N-CA 121.461 1.441 . . . . 0.0 111.618 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.475 0 N-CA-C 116.181 1.232 . . . . 0.0 116.181 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.46 100.02 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.69 1.996 . . . . 0.0 109.243 -170.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.87 -161.34 53.93 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.56 172.9 7.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.441 1.496 . . . . 0.0 112.563 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.34 -63.81 0.58 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 118.851 0.75 . . . . 0.0 114.086 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -134.28 174.31 4.81 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 129.471 3.108 . . . . 0.0 111.205 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -66.0 147.98 85.2 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 CA-C-N 124.023 2.473 . . . . 0.0 114.023 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -70.94 134.18 47.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.683 -1.261 . . . . 0.0 108.783 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.5 m -75.52 -39.67 58.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 119.834 -1.791 . . . . 0.0 114.992 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 mt -83.92 -71.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.082 1.753 . . . . 0.0 110.989 -172.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -138.71 143.97 39.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 122.312 1.053 . . . . 0.0 110.432 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.5 70.18 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.039 2.535 . . . . 0.0 114.118 -171.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.36 154.29 38.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 132.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.31 -42.75 92.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.638 -2.538 . . . . 0.0 113.303 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -135.73 169.06 18.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.425 1.49 . . . . 0.0 114.525 -175.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.37 156.8 32.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 130.105 3.362 . . . . 0.0 111.622 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -69.83 157.58 89.33 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 125.931 1.692 . . . . 0.0 113.073 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.18 169.89 14.32 Favored 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 126.465 4.777 . . . . 0.0 110.381 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 76.5 mtp . . . . . 0 C--O 1.25 1.1 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -169.785 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 CA-C-O 121.734 0.63 . . . . 0.0 111.675 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.92 118.89 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.336 1.454 . . . . 0.0 110.366 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.1 -162.38 51.57 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 119.878 1.217 . . . . 0.0 111.562 -170.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -131.57 168.31 17.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 119.525 -2.162 . . . . 0.0 111.009 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.57 -77.43 0.31 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 127.163 2.316 . . . . 0.0 113.658 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.64 161.02 43.95 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.301 1.84 . . . . 0.0 114.798 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.03 119.48 6.71 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 CA-C-N 120.634 1.262 . . . . 0.0 113.34 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -54.07 117.64 3.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.261 2.224 . . . . 0.0 109.254 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -62.63 -9.6 9.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.2 mt -137.48 -64.06 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.917 1.687 . . . . 0.0 111.142 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.5 mt -92.9 160.92 14.69 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.335 1.454 . . . . 0.0 113.815 -167.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -83.14 72.48 10.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.819 1.248 . . . . 0.0 113.7 -165.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -144.41 159.09 43.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.029 0.919 . . . . 0.0 111.395 167.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.47 -32.61 72.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 116.754 -1.593 . . . . 0.0 114.732 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -140.06 156.33 46.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.91 158.88 44.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.317 3.047 . . . . 0.0 111.581 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -96.9 140.97 22.41 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 127.941 2.497 . . . . 0.0 110.561 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -58.19 148.74 76.7 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.322 2.015 . . . . 0.0 113.36 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 97.6 mtp . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.629 -1.177 . . . . 0.0 113.296 -160.785 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.767 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.0 p -148.15 155.9 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.137 2.175 . . . . 0.0 107.108 161.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 54.06 -139.39 37.26 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 121.636 2.016 . . . . 0.0 113.582 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.99 146.8 49.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.727 1.611 . . . . 0.0 113.618 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.43 -78.54 0.08 OUTLIER Glycine 0 C--N 1.335 0.497 0 N-CA-C 116.906 1.523 . . . . 0.0 116.906 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -145.68 172.67 5.03 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 129.633 3.173 . . . . 0.0 111.782 -168.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.08 100.68 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.309 2.006 . . . . 0.0 111.216 169.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -81.04 74.66 8.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.357 1.463 . . . . 0.0 110.329 173.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -56.5 -7.72 0.44 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -159.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.0 mt -52.57 -46.05 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 127.395 2.278 . . . . 0.0 111.531 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tt -134.79 139.48 45.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.357 1.863 . . . . 0.0 110.216 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -72.49 80.19 1.06 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.457 1.103 . . . . 0.0 111.317 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -137.54 165.48 26.2 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.614 1.166 . . . . 0.0 110.436 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.04 155.23 40.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.469 1.108 . . . . 0.0 112.668 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 29.21 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.16 3.784 . . . . 0.0 113.42 147.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.25 146.63 46.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.59 2.356 . . . . 0.0 110.315 -177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -59.96 155.41 43.28 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 126.7 2.0 . . . . 0.0 112.421 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.8 163.78 8.75 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.154 2.57 . . . . 0.0 112.512 157.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 C--O 1.25 1.1 0 C-N-CA 123.732 0.813 . . . . 0.0 112.026 -164.914 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.504 0 CA-C-O 117.512 -1.715 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -152.59 152.49 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.848 2.059 . . . . 0.0 109.415 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.57 -160.99 43.36 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 119.183 0.901 . . . . 0.0 114.312 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.71 164.28 28.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.594 -1.533 . . . . 0.0 114.719 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.72 -154.76 19.34 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 124.735 1.159 . . . . 0.0 111.306 -158.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -50.51 150.32 4.89 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 126.876 2.07 . . . . 0.0 113.076 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.65 145.06 96.96 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.864 3.043 . . . . 0.0 113.788 -168.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -68.6 139.29 55.53 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.626 -1.296 . . . . 0.0 109.489 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -71.77 -79.36 0.07 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -75.03 -74.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.609 1.164 . . . . 0.0 112.015 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 tp -60.06 117.99 5.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.862 -1.774 . . . . 0.0 109.053 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -69.3 71.9 0.29 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.522 1.529 . . . . 0.0 112.984 -171.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -108.52 135.48 49.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.784 1.634 . . . . 0.0 107.705 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -56.16 -38.14 70.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.506 -1.371 . . . . 0.0 113.359 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -131.43 153.52 49.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.297 1.439 . . . . 0.0 108.508 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.82 153.15 42.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.471 1.908 . . . . 0.0 113.324 172.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -61.93 141.91 95.32 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.851 169.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.7 115.07 3.55 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.286 2.658 . . . . 0.0 110.085 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 62.4 mtm . . . . . 0 C--O 1.251 1.154 0 C-N-CA 127.536 2.334 . . . . 0.0 110.495 -178.04 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.47 112.26 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.237 2.215 . . . . 0.0 108.233 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.6 -163.38 27.27 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 126.6 2.048 . . . . 0.0 114.97 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -117.01 155.1 29.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.523 1.129 . . . . 0.0 112.106 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.437 ' H ' ' NE2' ' A' ' 15' ' ' GLN . . . 128.04 -137.18 9.59 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 127.187 2.327 . . . . 0.0 114.202 -169.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -63.1 150.89 87.64 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 128.071 2.549 . . . . 0.0 111.996 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -62.62 147.94 94.06 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.862 3.041 . . . . 0.0 112.985 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -96.82 87.01 4.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.231 -1.35 . . . . 0.0 113.052 -162.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -50.74 -30.22 13.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.2 mt -68.69 -26.51 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.425 1.49 . . . . 0.0 110.04 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.77 -152.03 0.49 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.135 2.174 . . . . 0.0 108.169 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -130.48 89.83 2.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.508 -1.37 . . . . 0.0 110.694 160.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -138.26 155.28 48.77 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.29 1.836 . . . . 0.0 110.361 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -56.58 -38.62 72.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.479 1.112 . . . . 0.0 113.782 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.437 ' NE2' ' H ' ' A' ' 5' ' ' GLY . 36.5 mt-30 -141.63 153.56 44.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.43 154.81 40.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.724 3.21 . . . . 0.0 110.802 157.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -76.06 151.49 83.98 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 116.662 -1.637 . . . . 0.0 108.454 159.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.2 162.37 30.18 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.078 2.519 . . . . 0.0 109.103 167.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.1 ptm . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.761 2.025 . . . . 0.0 115.311 -172.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 112.936 -0.065 . . . . 0.0 112.936 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 p -149.4 95.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.996 2.118 . . . . 0.0 113.603 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.07 -124.11 19.36 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 124.984 1.278 . . . . 0.0 112.034 -174.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.96 163.55 39.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.967 1.707 . . . . 0.0 114.023 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.37 -52.19 0.49 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 128.005 2.716 . . . . 0.0 113.114 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -139.88 175.39 3.23 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 131.421 3.888 . . . . 0.0 109.626 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.79 163.71 38.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 CA-C-N 124.869 2.775 . . . . 0.0 112.896 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -78.3 99.98 6.53 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 171.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 m -65.12 -15.36 62.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.49 -46.0 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.403 1.081 . . . . 0.0 112.616 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 tt -153.64 114.77 4.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.797 2.039 . . . . 0.0 109.707 173.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -63.9 109.2 1.69 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.002 0.921 . . . . 0.0 112.03 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -134.0 -81.46 0.46 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 165.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -123.13 -174.46 2.95 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.739 2.416 . . . . 0.0 111.146 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -66.28 166.07 12.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.45 178.95 9.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.494 2.718 . . . . 0.0 111.921 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -105.32 170.01 6.42 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 126.944 2.098 . . . . 0.0 111.6 161.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -77.67 -175.02 2.46 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.967 2.445 . . . . 0.0 111.973 167.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 48.6 ttp . . . . . 0 C--O 1.251 1.159 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.538 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 117.524 -1.709 . . . . 0.0 114.298 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 p -116.93 129.3 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 120.239 2.019 . . . . 0.0 110.453 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.87 -155.75 39.33 Favored Glycine 0 C--N 1.335 0.52 0 O-C-N 120.799 -1.188 . . . . 0.0 113.214 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.269 0.3 OUTLIER -134.38 165.53 24.93 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 120.369 -1.665 . . . . 0.0 113.638 175.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.37 -153.19 17.59 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 126.166 1.841 . . . . 0.0 110.961 -159.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.22 148.46 3.16 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 127.205 2.202 . . . . 0.0 114.703 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.77 149.05 72.63 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.854 3.036 . . . . 0.0 111.986 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -93.05 160.31 14.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 119.517 -1.989 . . . . 0.0 113.839 -160.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.0 m -97.95 -32.2 11.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -161.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -116.53 -69.25 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.215 1.406 . . . . 0.0 110.187 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -66.88 119.65 12.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.849 1.259 . . . . 0.0 109.842 177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.9 m -47.91 108.53 0.17 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.633 1.573 . . . . 0.0 112.073 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -156.48 144.38 19.47 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.638 -1.289 . . . . 0.0 113.855 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.44 -31.89 73.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 165.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -144.12 149.69 36.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 125.192 1.558 . . . . 0.0 113.882 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.7 161.78 34.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.086 2.555 . . . . 0.0 112.138 171.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.413 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 7.1 mmpt? -58.33 145.91 73.3 Favored Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 120.524 -1.36 . . . . 0.0 113.186 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.28 134.14 28.23 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 160.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.9 ttm . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.699 1.599 . . . . 0.0 112.67 -170.329 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.15 141.1 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 120.458 2.129 . . . . 0.0 111.325 159.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.22 -165.4 54.61 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 119.147 0.885 . . . . 0.0 112.981 -165.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -136.16 142.43 44.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.299 -1.118 . . . . 0.0 111.601 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.9 -113.16 0.55 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 126.156 1.836 . . . . 0.0 110.663 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.9 ptt85 -64.9 168.84 6.33 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 120.687 2.244 . . . . 0.0 112.719 168.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.82 161.38 39.5 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 CA-C-N 120.725 1.295 . . . . 0.0 113.523 163.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.62 158.78 30.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 119.42 -2.05 . . . . 0.0 112.029 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.8 m -83.94 -28.03 28.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.874 2.47 . . . . 0.0 114.377 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.7 mt -107.54 -79.95 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.564 1.546 . . . . 0.0 111.107 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.96 137.95 16.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.274 1.829 . . . . 0.0 109.701 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.283 12.4 t -71.61 74.44 0.8 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.235 1.014 . . . . 0.0 109.576 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -139.52 150.29 44.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 119.377 -2.077 . . . . 0.0 112.257 -166.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -86.37 -18.36 32.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.113 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -129.3 116.53 19.25 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.181 1.392 . . . . 0.0 112.872 -166.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.84 127.82 15.52 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.567 2.347 . . . . 0.0 109.659 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -77.43 124.88 86.82 Favored Pre-proline 0 N--CA 1.449 -0.505 0 O-C-N 119.281 -2.137 . . . . 0.0 108.269 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -60.82 165.48 11.82 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.469 2.78 . . . . 0.0 115.802 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 C--O 1.25 1.096 0 CA-C-O 116.254 -1.831 . . . . 0.0 111.143 -170.086 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 CA-C-O 119.534 -0.592 . . . . 0.0 112.84 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.61 65.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.741 1.216 . . . . 0.0 110.441 -162.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.99 177.86 37.05 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 127.895 2.664 . . . . 0.0 114.927 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -64.22 141.73 58.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 119.969 -1.901 . . . . 0.0 115.015 -169.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.93 -144.02 11.28 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.391 1.472 . . . . 0.0 112.792 -173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 164.88 12.82 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 125.765 1.626 . . . . 0.0 113.696 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -60.45 135.77 63.36 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 CA-C-N 122.759 2.021 . . . . 0.0 111.509 166.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -88.21 93.09 9.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.879 0.847 . . . . 0.0 110.886 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -67.81 -22.69 65.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.3 mt -79.66 -49.41 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.28 1.032 . . . . 0.0 112.931 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.4 116.5 16.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.824 1.649 . . . . 0.0 108.097 -174.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.8 m -48.78 95.63 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.577 2.351 . . . . 0.0 115.576 -166.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -150.83 163.85 37.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 129.367 3.067 . . . . 0.0 109.363 160.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.03 10.87 10.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.544 -1.348 . . . . 0.0 114.574 166.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -144.72 122.95 12.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.378 1.871 . . . . 0.0 114.175 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.43 133.43 25.83 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.907 2.883 . . . . 0.0 112.068 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -46.2 115.64 3.14 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 126.472 1.909 . . . . 0.0 110.577 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -64.91 119.95 7.09 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 124.418 3.412 . . . . 0.0 111.278 -166.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.2 ttp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 128.389 2.676 . . . . 0.0 111.327 177.399 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 117.623 1.809 . . . . 0.0 117.623 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.53 169.73 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 126.984 2.114 . . . . 0.0 108.36 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.84 -143.54 45.17 Favored Glycine 0 CA--C 1.522 0.511 0 O-C-N 119.61 -1.932 . . . . 0.0 113.594 161.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.7 161.05 38.9 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.414 1.086 . . . . 0.0 113.417 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.14 -78.18 0.21 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 126.469 1.985 . . . . 0.0 112.97 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.71 167.14 23.41 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 130.253 3.421 . . . . 0.0 114.025 -167.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -70.73 113.09 3.42 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 CA-C-N 122.908 2.074 . . . . 0.0 115.523 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -68.63 105.39 2.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.371 1.468 . . . . 0.0 110.448 163.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -58.04 -19.11 28.95 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 117.678 2.473 . . . . 0.0 117.678 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.9 mm -94.98 -16.74 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.574 1.95 . . . . 0.0 108.821 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.2 tp -146.63 93.45 2.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 119.825 -1.797 . . . . 0.0 112.028 -168.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.0 p -64.23 16.25 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 119.563 3.172 . . . . 0.0 119.563 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -52.98 104.87 0.1 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.025 0.93 . . . . 0.0 111.361 159.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.4 138.17 56.49 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 124.149 0.906 . . . . 0.0 111.518 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.49 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.503 1.921 . . . . 0.0 112.223 -157.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.1 -170.14 2.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.258 1.823 . . . . 0.0 111.667 170.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -148.27 135.74 10.73 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 126.85 2.06 . . . . 0.0 108.342 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -62.57 172.46 4.48 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.373 2.049 . . . . 0.0 110.195 171.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 C--O 1.25 1.086 0 CA-C-N 113.64 -1.618 . . . . 0.0 114.768 -177.109 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.527 0 CA-C-O 118.184 -1.342 . . . . 0.0 112.839 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.46 114.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 128.996 2.919 . . . . 0.0 110.841 168.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.11 -153.16 52.86 Favored Glycine 0 N--CA 1.448 -0.546 0 O-C-N 121.098 -1.001 . . . . 0.0 111.84 -170.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.03 166.92 23.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.83 -87.91 0.2 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 125.769 1.652 . . . . 0.0 110.804 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -76.42 168.27 29.49 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 124.889 1.275 . . . . 0.0 109.816 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -67.93 151.66 77.78 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 CA-C-N 121.379 1.528 . . . . 0.0 112.828 161.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -82.41 122.53 28.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.037 -1.039 . . . . 0.0 110.211 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 m -59.19 -12.37 5.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mt -120.23 140.26 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.55 98.22 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.96 1.704 . . . . 0.0 110.293 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -151.29 -67.48 0.18 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.417 -0.802 . . . . 0.0 110.061 -168.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -142.54 162.22 36.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.323 2.649 . . . . 0.0 109.214 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -54.7 -35.83 64.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.583 1.553 . . . . 0.0 114.454 -168.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -136.25 174.55 10.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.096 2.159 . . . . 0.0 111.811 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.66 162.09 39.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.195 -1.566 . . . . 0.0 109.863 167.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -66.71 172.52 3.23 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.231 1.012 . . . . 0.0 111.354 163.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.9 171.74 0.97 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 124.715 3.61 . . . . 0.0 114.994 157.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 17.2 ttt . . . . . 0 C--O 1.249 1.064 0 C-N-CA 127.36 2.264 . . . . 0.0 113.374 178.836 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.52 0 N-CA-C 118.052 1.981 . . . . 0.0 118.052 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.5 137.18 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.77 2.028 . . . . 0.0 110.971 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.34 -150.92 20.7 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.072 1.32 . . . . 0.0 116.162 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -145.36 151.47 38.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 119.478 1.639 . . . . 0.0 113.418 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.72 -114.69 0.8 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 126.779 2.133 . . . . 0.0 109.894 -165.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 160.72 78.09 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 127.861 2.464 . . . . 0.0 113.514 172.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.67 138.17 62.81 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 CA-C-N 121.057 1.413 . . . . 0.0 111.691 151.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.7 164.83 25.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.416 0.686 . . . . 0.0 111.871 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.8 m -77.32 -57.51 3.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.688 -0.633 . . . . 0.0 111.668 -169.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.8 mt -94.72 -63.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -166.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.23 130.34 42.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.178 1.391 . . . . 0.0 109.178 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.9 t -69.05 21.65 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -63.04 132.31 51.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.113 2.165 . . . . 0.0 111.346 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -62.14 -15.84 48.59 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.476 -1.726 . . . . 0.0 113.398 168.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.0 120.55 16.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 121.515 1.961 . . . . 0.0 113.186 -172.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.37 153.8 41.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.123 2.169 . . . . 0.0 113.644 162.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -72.42 134.1 82.57 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-O 117.385 -1.293 . . . . 0.0 111.856 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.7 88.48 1.04 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.573 2.182 . . . . 0.0 110.08 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 40.6 mmm . . . . . 0 C--O 1.25 1.117 0 C-N-CA 129.953 3.301 . . . . 0.0 115.161 178.173 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.439 0 CA-C-O 117.433 -1.76 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.34 6.3 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 119.093 1.447 . . . . 0.0 114.585 -170.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.71 -155.38 25.34 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 125.811 1.672 . . . . 0.0 109.486 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.96 150.56 39.04 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 120.694 2.247 . . . . 0.0 114.92 171.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.66 -125.35 2.97 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.999 1.761 . . . . 0.0 115.532 -170.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.53 164.97 4.59 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 128.216 2.606 . . . . 0.0 113.929 171.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.49 155.34 59.76 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.833 3.689 . . . . 0.0 110.511 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.72 136.85 56.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.838 -1.164 . . . . 0.0 112.381 -173.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.2 p -64.48 -31.28 72.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.876 1.671 . . . . 0.0 115.026 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.5 pt -132.23 -13.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.1 mt -105.9 159.08 16.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.589 -1.319 . . . . 0.0 110.676 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -82.9 65.11 7.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.562 -1.336 . . . . 0.0 109.455 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -137.34 159.84 40.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.393 1.477 . . . . 0.0 110.567 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -105.65 -9.44 17.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.565 1.166 . . . . 0.0 111.623 -166.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -128.17 118.23 23.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.724 1.147 . . . . 0.0 112.054 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.0 150.79 37.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 129.096 2.958 . . . . 0.0 112.308 164.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.441 ' HE2' ' HD2' ' A' ' 18' ' ' PRO . 3.0 mmpt? -74.42 171.88 10.17 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 120.61 -1.306 . . . . 0.0 110.909 163.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 59.0 Cg_endo -62.36 151.72 81.01 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 CA-C-N 120.766 1.309 . . . . 0.0 111.275 150.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.2 ttt . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.064 1.346 . . . . 0.0 112.467 177.298 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 CA-C-O 118.687 -1.063 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.23 116.09 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 126.515 1.926 . . . . 0.0 110.824 -177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.83 -146.03 24.01 Favored Glycine 0 CA--C 1.523 0.546 0 O-C-N 119.918 -1.738 . . . . 0.0 113.095 -168.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -145.28 166.73 24.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.516 1.526 . . . . 0.0 110.145 174.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.99 -86.67 0.23 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.942 1.258 . . . . 0.0 115.075 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -122.39 173.52 4.11 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 127.683 2.393 . . . . 0.0 111.52 -174.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -48.97 154.07 3.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 124.042 3.162 . . . . 0.0 117.625 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -107.87 128.58 54.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.571 1.548 . . . . 0.0 109.358 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 p -69.89 -52.25 26.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -171.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.7 mt -99.29 -65.5 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.532 0.733 . . . . 0.0 110.056 -173.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.61 118.9 7.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.604 -1.31 . . . . 0.0 113.788 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -72.68 77.72 1.1 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.626 2.371 . . . . 0.0 110.873 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.44 172.88 12.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.38 2.272 . . . . 0.0 108.12 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -59.08 -67.6 0.35 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.429 1.491 . . . . 0.0 113.627 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -136.7 170.66 15.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.068 2.147 . . . . 0.0 111.125 -172.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.36 171.12 14.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 129.99 3.316 . . . . 0.0 109.012 167.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -66.28 167.01 13.74 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 120.99 -1.069 . . . . 0.0 108.896 159.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -59.32 148.76 84.9 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 CA-C-N 121.554 1.591 . . . . 0.0 111.072 158.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 53.2 mtm . . . . . 0 C--O 1.25 1.126 0 C-N-CA 125.93 1.692 . . . . 0.0 112.529 -163.263 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 119.251 -0.75 . . . . 0.0 114.687 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.93 140.54 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 118.194 0.997 . . . . 0.0 109.997 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.98 -164.66 53.1 Favored Glycine 0 CA--C 1.523 0.55 0 O-C-N 120.595 -1.316 . . . . 0.0 113.445 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -142.15 165.31 27.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.521 -0.987 . . . . 0.0 112.413 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.48 -26.74 3.31 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 128.562 2.982 . . . . 0.0 114.196 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -150.51 174.53 3.44 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 127.035 2.134 . . . . 0.0 110.546 -173.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.15 159.29 50.22 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.712 2.275 . . . . 0.0 111.161 169.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -84.56 154.47 22.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.952 1.701 . . . . 0.0 112.684 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.1 p -124.4 -2.78 7.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.861 2.064 . . . . 0.0 114.908 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.2 mt -123.72 -43.12 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.846 2.058 . . . . 0.0 110.16 -170.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.8 mt -112.33 154.07 26.26 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.595 1.158 . . . . 0.0 111.201 169.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.1 m -69.96 87.1 0.54 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.28 1.032 . . . . 0.0 108.866 172.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -143.03 152.52 41.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.465 1.106 . . . . 0.0 110.931 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -79.62 -11.19 59.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -133.38 134.54 43.84 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.096 2.158 . . . . 0.0 111.707 -170.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.19 163.13 36.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.478 1.111 . . . . 0.0 110.699 155.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -87.83 145.58 37.06 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 127.326 2.251 . . . . 0.0 110.198 155.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.05 159.96 32.12 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 CA-C-N 121.443 1.551 . . . . 0.0 111.423 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.6 ttt . . . . . 0 C--O 1.25 1.11 0 C-N-CA 124.772 1.229 . . . . 0.0 111.325 163.71 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.507 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.03 133.43 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 118.25 1.025 . . . . 0.0 111.216 163.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.72 -159.71 7.09 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 125.195 1.378 . . . . 0.0 115.584 -170.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -141.28 169.73 17.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.219 1.408 . . . . 0.0 113.006 173.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.23 -154.92 16.66 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 128.086 2.755 . . . . 0.0 111.629 -154.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -34.42 138.57 0.32 Allowed Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 128.3 2.64 . . . . 0.0 115.789 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.6 146.4 43.65 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.117 2.545 . . . . 0.0 115.664 -170.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -68.51 133.41 48.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.789 1.236 . . . . 0.0 111.333 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 m -118.41 16.09 13.85 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.407 1.483 . . . . 0.0 113.856 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.1 mt -118.31 -63.21 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 128.565 2.746 . . . . 0.0 108.16 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -87.27 166.63 14.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.279 1.832 . . . . 0.0 109.432 173.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -77.98 82.37 4.34 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.204 1.401 . . . . 0.0 110.586 161.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -142.41 144.04 32.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.794 1.238 . . . . 0.0 112.629 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.42 -6.82 59.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -146.25 137.87 24.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.544 -1.217 . . . . 0.0 109.731 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.03 165.67 33.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.461 1.504 . . . . 0.0 113.652 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -59.95 134.66 90.05 Favored Pre-proline 0 N--CA 1.449 -0.524 0 O-C-N 119.719 -1.863 . . . . 0.0 111.193 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -66.15 143.5 71.66 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.574 2.183 . . . . 0.0 109.839 168.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 56.5 ttm . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.382 1.473 . . . . 0.0 111.33 -178.224 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.55 0 CA-C-O 122.344 0.969 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.21 136.26 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 O-C-N 119.655 -2.085 . . . . 0.0 112.554 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.11 -154.27 27.53 Favored Glycine 0 CA--C 1.522 0.504 0 O-C-N 120.54 -1.35 . . . . 0.0 114.735 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -145.59 168.66 20.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.173 -0.604 . . . . 0.0 110.929 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.18 -19.45 17.55 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 118.177 2.031 . . . . 0.0 118.177 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -139.48 171.09 8.54 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 126.978 2.111 . . . . 0.0 108.143 171.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.39 152.84 75.15 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 CA-C-N 122.768 2.024 . . . . 0.0 113.288 168.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -71.93 162.11 29.95 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.034 -1.666 . . . . 0.0 112.479 165.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -103.33 -21.22 13.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.221 2.208 . . . . 0.0 115.769 170.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.7 mt -135.77 118.67 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.845 1.658 . . . . 0.0 109.312 -159.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.4 tp 70.26 142.27 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 129.67 3.188 . . . . 0.0 111.77 -170.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 m -60.85 88.87 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.619 1.168 . . . . 0.0 112.212 171.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -134.66 171.82 13.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.726 2.411 . . . . 0.0 110.956 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -78.65 -158.17 0.13 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 118.204 -2.81 . . . . 0.0 111.185 170.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -48.83 158.82 0.29 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.738 2.415 . . . . 0.0 115.772 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.65 -178.53 5.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.765 2.826 . . . . 0.0 112.466 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -135.85 151.42 74.01 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 130.22 3.408 . . . . 0.0 108.623 168.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -63.75 174.46 3.72 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.079 1.853 . . . . 0.0 113.19 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.7 ptm . . . . . 0 C--O 1.25 1.12 0 C-N-CA 127.578 2.351 . . . . 0.0 116.678 179.544 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.539 0 CA-C-O 122.056 0.809 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.61 80.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.169 2.588 . . . . 0.0 109.892 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 113.26 -135.92 13.0 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 127.689 2.566 . . . . 0.0 114.682 168.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -144.99 149.42 35.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.374 1.087 . . . . 0.0 109.615 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.75 -62.14 0.48 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 125.262 1.411 . . . . 0.0 114.565 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.98 156.71 68.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 112.424 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.43 136.53 74.97 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.162 1.908 . . . . 0.0 111.952 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -64.13 146.87 53.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.735 2.014 . . . . 0.0 110.597 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.2 m -112.02 -10.09 13.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 mt -73.49 -60.95 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 119.997 1.271 . . . . 0.0 110.776 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.6 mt -125.94 171.06 11.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.368 1.467 . . . . 0.0 111.103 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -74.87 83.5 2.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.464 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -124.45 123.1 39.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.281 1.832 . . . . 0.0 108.656 166.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -57.18 -21.92 36.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.78 1.632 . . . . 0.0 113.164 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -132.99 118.16 18.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.787 2.035 . . . . 0.0 110.23 -163.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.81 154.73 40.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.461 2.305 . . . . 0.0 110.311 168.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -66.41 158.25 78.88 Favored Pre-proline 0 N--CA 1.45 -0.451 0 O-C-N 120.897 -1.127 . . . . 0.0 111.897 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.65 101.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.413 2.076 . . . . 0.0 110.367 145.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 30.7 tpp . . . . . 0 C--O 1.25 1.118 0 C-N-CA 127.859 2.464 . . . . 0.0 112.15 -169.311 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.491 0 N-CA-C 117.856 1.902 . . . . 0.0 117.856 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.5 p -141.03 135.97 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 120.778 -1.425 . . . . 0.0 112.529 174.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 61.02 -110.6 3.16 Favored Glycine 0 CA--C 1.522 0.5 0 O-C-N 120.095 -1.628 . . . . 0.0 115.544 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -136.39 150.79 48.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.153 2.181 . . . . 0.0 113.153 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.36 -145.2 13.39 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.526 1.536 . . . . 0.0 115.116 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.68 175.76 0.3 Allowed Pre-proline 0 N--CA 1.449 -0.486 1 C-N-CA 132.692 4.397 . . . . 0.0 115.143 173.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.02 106.67 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.232 3.288 . . . . 0.0 113.464 165.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -74.21 101.8 4.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.798 1.239 . . . . 0.0 109.751 174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 m -76.78 28.57 0.13 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.383 2.673 . . . . 0.0 113.865 -168.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.66 -60.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.697 2.399 . . . . 0.0 108.163 168.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.59 89.69 3.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.414 1.486 . . . . 0.0 109.796 170.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -81.67 67.97 7.84 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.56 1.144 . . . . 0.0 112.359 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -77.94 66.32 3.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 123.863 1.792 . . . . 0.0 112.071 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 46.59 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.346 3.059 . . . . 0.0 113.75 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -100.04 117.89 35.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.27 146.47 29.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.786 1.279 . . . . 0.0 113.378 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -75.92 147.11 80.26 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 128.392 2.677 . . . . 0.0 110.601 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.25 143.03 69.19 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.653 1.569 . . . . 0.0 112.335 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 71.1 mmm . . . . . 0 C--O 1.25 1.107 0 C-N-CA 126.283 1.833 . . . . 0.0 112.666 173.918 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.07 152.88 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.38 1.872 . . . . 0.0 110.027 150.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.1 -137.49 31.67 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 119.957 1.253 . . . . 0.0 113.489 173.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -140.47 146.09 37.77 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.346 1.858 . . . . 0.0 114.32 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.8 -86.49 0.14 Allowed Glycine 0 C--N 1.336 0.547 0 O-C-N 121.467 -0.771 . . . . 0.0 114.043 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 161.59 45.4 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 128.595 2.758 . . . . 0.0 112.542 -172.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.96 124.46 13.57 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 CA-C-N 122.514 1.933 . . . . 0.0 110.911 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -58.23 114.62 2.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.151 1.381 . . . . 0.0 113.781 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.0 m -63.01 -24.88 68.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.2 mt -85.21 -55.17 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 119.711 1.141 . . . . 0.0 108.709 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -138.09 112.62 8.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 116.831 -1.557 . . . . 0.0 108.412 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -65.0 77.03 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -162.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -75.48 139.51 42.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 112.693 -2.049 . . . . 0.0 112.649 159.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -70.24 121.68 18.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.85 0.833 . . . . 0.0 111.845 170.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 59.06 104.47 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.689 2.396 . . . . 0.0 115.782 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.15 146.41 42.74 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 129.334 3.054 . . . . 0.0 111.519 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -63.24 113.87 10.91 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 127.846 2.459 . . . . 0.0 110.179 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.99 153.75 76.75 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.461 1.441 . . . . 0.0 111.618 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 40.0 ttm . . . . . 0 C--O 1.25 1.104 0 C-N-CA 126.185 1.794 . . . . 0.0 112.761 175.634 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.475 0 N-CA-C 116.181 1.232 . . . . 0.0 116.181 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.46 100.02 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.69 1.996 . . . . 0.0 109.243 -170.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.87 -161.34 53.93 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.56 172.9 7.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.441 1.496 . . . . 0.0 112.563 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.34 -63.81 0.58 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 118.851 0.75 . . . . 0.0 114.086 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -134.28 174.31 4.81 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 129.471 3.108 . . . . 0.0 111.205 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -66.0 147.98 85.2 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 CA-C-N 124.023 2.473 . . . . 0.0 114.023 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -70.94 134.18 47.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.683 -1.261 . . . . 0.0 108.783 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.5 m -75.52 -39.67 58.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 119.834 -1.791 . . . . 0.0 114.992 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 mt -83.92 -71.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.082 1.753 . . . . 0.0 110.989 -172.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -138.71 143.97 39.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 122.312 1.053 . . . . 0.0 110.432 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.5 70.18 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.039 2.535 . . . . 0.0 114.118 -171.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.36 154.29 38.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 132.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.31 -42.75 92.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.638 -2.538 . . . . 0.0 113.303 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -135.73 169.06 18.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.425 1.49 . . . . 0.0 114.525 -175.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.37 156.8 32.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 130.105 3.362 . . . . 0.0 111.622 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -69.83 157.58 89.33 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 125.931 1.692 . . . . 0.0 113.073 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.448 -1.151 1 C-N-CA 126.465 4.777 . . . . 0.0 110.381 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 CA-C-O 121.734 0.63 . . . . 0.0 111.675 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.92 118.89 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.336 1.454 . . . . 0.0 110.366 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.1 -162.38 51.57 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 119.878 1.217 . . . . 0.0 111.562 -170.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -131.57 168.31 17.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 119.525 -2.162 . . . . 0.0 111.009 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.57 -77.43 0.31 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 127.163 2.316 . . . . 0.0 113.658 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.64 161.02 43.95 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.301 1.84 . . . . 0.0 114.798 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.03 119.48 6.71 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 CA-C-N 120.634 1.262 . . . . 0.0 113.34 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -54.07 117.64 3.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.261 2.224 . . . . 0.0 109.254 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -62.63 -9.6 9.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.2 mt -137.48 -64.06 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.917 1.687 . . . . 0.0 111.142 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.5 mt -92.9 160.92 14.69 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.335 1.454 . . . . 0.0 113.815 -167.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -83.14 72.48 10.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.819 1.248 . . . . 0.0 113.7 -165.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -144.41 159.09 43.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.029 0.919 . . . . 0.0 111.395 167.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.47 -32.61 72.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 116.754 -1.593 . . . . 0.0 114.732 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -140.06 156.33 46.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.91 158.88 44.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.317 3.047 . . . . 0.0 111.581 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -96.9 140.97 22.41 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 127.941 2.497 . . . . 0.0 110.561 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.448 -1.16 0 C-N-CA 122.322 2.015 . . . . 0.0 113.36 -179.37 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.767 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.0 p -148.15 155.9 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.137 2.175 . . . . 0.0 107.108 161.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 54.06 -139.39 37.26 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 121.636 2.016 . . . . 0.0 113.582 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.99 146.8 49.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.727 1.611 . . . . 0.0 113.618 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.43 -78.54 0.08 OUTLIER Glycine 0 C--N 1.335 0.497 0 N-CA-C 116.906 1.523 . . . . 0.0 116.906 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -145.68 172.67 5.03 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 129.633 3.173 . . . . 0.0 111.782 -168.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.08 100.68 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.309 2.006 . . . . 0.0 111.216 169.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . 29.2 t0 -81.04 74.66 8.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.357 1.463 . . . . 0.0 110.329 173.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -56.5 -7.72 0.44 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -159.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.0 mt -52.57 -46.05 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 127.395 2.278 . . . . 0.0 111.531 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tt -134.79 139.48 45.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.357 1.863 . . . . 0.0 110.216 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -72.49 80.19 1.06 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.457 1.103 . . . . 0.0 111.317 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -137.54 165.48 26.2 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.614 1.166 . . . . 0.0 110.436 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.04 155.23 40.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.469 1.108 . . . . 0.0 112.668 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 29.21 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.16 3.784 . . . . 0.0 113.42 147.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 8' ' ' ASP . . . -136.25 146.63 46.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.59 2.356 . . . . 0.0 110.315 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -59.96 155.41 43.28 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 126.7 2.0 . . . . 0.0 112.421 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo . . . . . 0 N--CA 1.45 -1.088 0 C-N-CA 123.154 2.57 . . . . 0.0 112.512 157.41 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.504 0 CA-C-O 117.512 -1.715 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -152.59 152.49 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.848 2.059 . . . . 0.0 109.415 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.57 -160.99 43.36 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 119.183 0.901 . . . . 0.0 114.312 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.71 164.28 28.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.594 -1.533 . . . . 0.0 114.719 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.72 -154.76 19.34 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 124.735 1.159 . . . . 0.0 111.306 -158.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -50.51 150.32 4.89 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 126.876 2.07 . . . . 0.0 113.076 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.65 145.06 96.96 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.864 3.043 . . . . 0.0 113.788 -168.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -68.6 139.29 55.53 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.626 -1.296 . . . . 0.0 109.489 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -71.77 -79.36 0.07 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -75.03 -74.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.609 1.164 . . . . 0.0 112.015 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 tp -60.06 117.99 5.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.862 -1.774 . . . . 0.0 109.053 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -69.3 71.9 0.29 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.522 1.529 . . . . 0.0 112.984 -171.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -108.52 135.48 49.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.784 1.634 . . . . 0.0 107.705 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -56.16 -38.14 70.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.506 -1.371 . . . . 0.0 113.359 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -131.43 153.52 49.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.297 1.439 . . . . 0.0 108.508 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.82 153.15 42.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.471 1.908 . . . . 0.0 113.324 172.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -61.93 141.91 95.32 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.851 169.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 N--CA 1.449 -1.094 0 C-N-CA 123.286 2.658 . . . . 0.0 110.085 177.609 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.47 112.26 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.237 2.215 . . . . 0.0 108.233 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.6 -163.38 27.27 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 126.6 2.048 . . . . 0.0 114.97 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -117.01 155.1 29.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.523 1.129 . . . . 0.0 112.106 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.04 -137.18 9.59 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 127.187 2.327 . . . . 0.0 114.202 -169.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -63.1 150.89 87.64 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 128.071 2.549 . . . . 0.0 111.996 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -62.62 147.94 94.06 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.862 3.041 . . . . 0.0 112.985 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -96.82 87.01 4.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.231 -1.35 . . . . 0.0 113.052 -162.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -50.74 -30.22 13.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.2 mt -68.69 -26.51 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.425 1.49 . . . . 0.0 110.04 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.77 -152.03 0.49 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.135 2.174 . . . . 0.0 108.169 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -130.48 89.83 2.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.508 -1.37 . . . . 0.0 110.694 160.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -138.26 155.28 48.77 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.29 1.836 . . . . 0.0 110.361 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -56.58 -38.62 72.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.479 1.112 . . . . 0.0 113.782 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -141.63 153.56 44.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.43 154.81 40.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.724 3.21 . . . . 0.0 110.802 157.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -76.06 151.49 83.98 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 116.662 -1.637 . . . . 0.0 108.454 159.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.448 -1.15 0 C-N-CA 123.078 2.519 . . . . 0.0 109.103 167.517 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 112.936 -0.065 . . . . 0.0 112.936 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 p -149.4 95.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.996 2.118 . . . . 0.0 113.603 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.07 -124.11 19.36 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 124.984 1.278 . . . . 0.0 112.034 -174.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.96 163.55 39.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.967 1.707 . . . . 0.0 114.023 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.37 -52.19 0.49 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 128.005 2.716 . . . . 0.0 113.114 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -139.88 175.39 3.23 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 131.421 3.888 . . . . 0.0 109.626 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.79 163.71 38.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 CA-C-N 124.869 2.775 . . . . 0.0 112.896 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -78.3 99.98 6.53 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 171.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 m -65.12 -15.36 62.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.49 -46.0 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.403 1.081 . . . . 0.0 112.616 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 tt -153.64 114.77 4.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.797 2.039 . . . . 0.0 109.707 173.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -63.9 109.2 1.69 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.002 0.921 . . . . 0.0 112.03 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -134.0 -81.46 0.46 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 165.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -123.13 -174.46 2.95 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.739 2.416 . . . . 0.0 111.146 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -66.28 166.07 12.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.45 178.95 9.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.494 2.718 . . . . 0.0 111.921 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -105.32 170.01 6.42 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 126.944 2.098 . . . . 0.0 111.6 161.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.449 -1.124 0 C-N-CA 122.967 2.445 . . . . 0.0 111.973 167.494 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 117.524 -1.709 . . . . 0.0 114.298 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 p -116.93 129.3 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 120.239 2.019 . . . . 0.0 110.453 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.87 -155.75 39.33 Favored Glycine 0 C--N 1.335 0.52 0 O-C-N 120.799 -1.188 . . . . 0.0 113.214 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.269 0.3 OUTLIER -134.38 165.53 24.93 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 120.369 -1.665 . . . . 0.0 113.638 175.239 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.37 -153.19 17.59 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 126.166 1.841 . . . . 0.0 110.961 -159.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.22 148.46 3.16 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 127.205 2.202 . . . . 0.0 114.703 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.77 149.05 72.63 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.854 3.036 . . . . 0.0 111.986 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -93.05 160.31 14.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 119.517 -1.989 . . . . 0.0 113.839 -160.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.0 m -97.95 -32.2 11.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -161.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -116.53 -69.25 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.215 1.406 . . . . 0.0 110.187 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.4 mm? -66.88 119.65 12.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.849 1.259 . . . . 0.0 109.842 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.9 m -47.91 108.53 0.17 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.633 1.573 . . . . 0.0 112.073 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -156.48 144.38 19.47 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.638 -1.289 . . . . 0.0 113.855 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.44 -31.89 73.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 165.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -144.12 149.69 36.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 125.192 1.558 . . . . 0.0 113.882 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.7 161.78 34.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.086 2.555 . . . . 0.0 112.138 171.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 7.1 mmpt? -58.33 145.91 73.3 Favored Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 120.524 -1.36 . . . . 0.0 113.186 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 N--CA 1.45 -1.076 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 160.168 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.15 141.1 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 120.458 2.129 . . . . 0.0 111.325 159.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.22 -165.4 54.61 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 119.147 0.885 . . . . 0.0 112.981 -165.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -136.16 142.43 44.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.299 -1.118 . . . . 0.0 111.601 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.9 -113.16 0.55 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 126.156 1.836 . . . . 0.0 110.663 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.9 ptt85 -64.9 168.84 6.33 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 120.687 2.244 . . . . 0.0 112.719 168.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.82 161.38 39.5 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 CA-C-N 120.725 1.295 . . . . 0.0 113.523 163.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.62 158.78 30.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 119.42 -2.05 . . . . 0.0 112.029 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.8 m -83.94 -28.03 28.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.874 2.47 . . . . 0.0 114.377 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.7 mt -107.54 -79.95 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.564 1.546 . . . . 0.0 111.107 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.96 137.95 16.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.274 1.829 . . . . 0.0 109.701 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.283 12.4 t -71.61 74.44 0.8 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.235 1.014 . . . . 0.0 109.576 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -139.52 150.29 44.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 119.377 -2.077 . . . . 0.0 112.257 -166.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -86.37 -18.36 32.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.113 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -129.3 116.53 19.25 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.181 1.392 . . . . 0.0 112.872 -166.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.84 127.82 15.52 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.567 2.347 . . . . 0.0 109.659 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -77.43 124.88 86.82 Favored Pre-proline 0 N--CA 1.449 -0.505 0 O-C-N 119.281 -2.137 . . . . 0.0 108.269 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 0 N--CA 1.449 -1.129 0 C-N-CA 123.469 2.78 . . . . 0.0 115.802 -173.249 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 CA-C-O 119.534 -0.592 . . . . 0.0 112.84 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.61 65.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.741 1.216 . . . . 0.0 110.441 -162.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.99 177.86 37.05 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 127.895 2.664 . . . . 0.0 114.927 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -64.22 141.73 58.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 119.969 -1.901 . . . . 0.0 115.015 -169.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.93 -144.02 11.28 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.391 1.472 . . . . 0.0 112.792 -173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 164.88 12.82 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 125.765 1.626 . . . . 0.0 113.696 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -60.45 135.77 63.36 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 CA-C-N 122.759 2.021 . . . . 0.0 111.509 166.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -88.21 93.09 9.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.879 0.847 . . . . 0.0 110.886 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -67.81 -22.69 65.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.3 mt -79.66 -49.41 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.28 1.032 . . . . 0.0 112.931 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.4 116.5 16.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.824 1.649 . . . . 0.0 108.097 -174.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.8 m -48.78 95.63 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.577 2.351 . . . . 0.0 115.576 -166.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -150.83 163.85 37.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 129.367 3.067 . . . . 0.0 109.363 160.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.03 10.87 10.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.544 -1.348 . . . . 0.0 114.574 166.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -144.72 122.95 12.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.378 1.871 . . . . 0.0 114.175 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.43 133.43 25.83 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.907 2.883 . . . . 0.0 112.068 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -46.2 115.64 3.14 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 126.472 1.909 . . . . 0.0 110.577 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.449 -1.123 0 C-N-CA 124.418 3.412 . . . . 0.0 111.278 -166.363 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 117.623 1.809 . . . . 0.0 117.623 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.53 169.73 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 126.984 2.114 . . . . 0.0 108.36 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.84 -143.54 45.17 Favored Glycine 0 CA--C 1.522 0.511 0 O-C-N 119.61 -1.932 . . . . 0.0 113.594 161.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.7 161.05 38.9 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.414 1.086 . . . . 0.0 113.417 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.14 -78.18 0.21 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 126.469 1.985 . . . . 0.0 112.97 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.71 167.14 23.41 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 130.253 3.421 . . . . 0.0 114.025 -167.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -70.73 113.09 3.42 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 CA-C-N 122.908 2.074 . . . . 0.0 115.523 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -68.63 105.39 2.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.371 1.468 . . . . 0.0 110.448 163.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -58.04 -19.11 28.95 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 117.678 2.473 . . . . 0.0 117.678 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.9 mm -94.98 -16.74 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.574 1.95 . . . . 0.0 108.821 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.2 tp -146.63 93.45 2.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 119.825 -1.797 . . . . 0.0 112.028 -168.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.0 p -64.23 16.25 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 119.563 3.172 . . . . 0.0 119.563 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -52.98 104.87 0.1 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.025 0.93 . . . . 0.0 111.361 159.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.4 138.17 56.49 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 124.149 0.906 . . . . 0.0 111.518 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 52.49 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.503 1.921 . . . . 0.0 112.223 -157.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.1 -170.14 2.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.258 1.823 . . . . 0.0 111.667 170.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -148.27 135.74 10.73 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 126.85 2.06 . . . . 0.0 108.342 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 N--CA 1.449 -1.14 0 C-N-CA 122.373 2.049 . . . . 0.0 110.195 171.416 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.527 0 CA-C-O 118.184 -1.342 . . . . 0.0 112.839 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.46 114.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 128.996 2.919 . . . . 0.0 110.841 168.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.11 -153.16 52.86 Favored Glycine 0 N--CA 1.448 -0.546 0 O-C-N 121.098 -1.001 . . . . 0.0 111.84 -170.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.03 166.92 23.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.83 -87.91 0.2 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 125.769 1.652 . . . . 0.0 110.804 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -76.42 168.27 29.49 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 124.889 1.275 . . . . 0.0 109.816 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -67.93 151.66 77.78 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 CA-C-N 121.379 1.528 . . . . 0.0 112.828 161.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -82.41 122.53 28.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.037 -1.039 . . . . 0.0 110.211 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 m -59.19 -12.37 5.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mt -120.23 140.26 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.55 98.22 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.96 1.704 . . . . 0.0 110.293 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -151.29 -67.48 0.18 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.417 -0.802 . . . . 0.0 110.061 -168.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -142.54 162.22 36.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.323 2.649 . . . . 0.0 109.214 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -54.7 -35.83 64.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.583 1.553 . . . . 0.0 114.454 -168.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -136.25 174.55 10.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.096 2.159 . . . . 0.0 111.811 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.66 162.09 39.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.195 -1.566 . . . . 0.0 109.863 167.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -66.71 172.52 3.23 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.231 1.012 . . . . 0.0 111.354 163.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.45 -1.073 0 C-N-CA 124.715 3.61 . . . . 0.0 114.994 157.518 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.52 0 N-CA-C 118.052 1.981 . . . . 0.0 118.052 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.5 137.18 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.77 2.028 . . . . 0.0 110.971 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.34 -150.92 20.7 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.072 1.32 . . . . 0.0 116.162 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -145.36 151.47 38.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 119.478 1.639 . . . . 0.0 113.418 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.72 -114.69 0.8 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 126.779 2.133 . . . . 0.0 109.894 -165.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 160.72 78.09 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 127.861 2.464 . . . . 0.0 113.514 172.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.67 138.17 62.81 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 CA-C-N 121.057 1.413 . . . . 0.0 111.691 151.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.7 164.83 25.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.416 0.686 . . . . 0.0 111.871 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.8 m -77.32 -57.51 3.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.688 -0.633 . . . . 0.0 111.668 -169.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.8 mt -94.72 -63.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -166.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.23 130.34 42.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.178 1.391 . . . . 0.0 109.178 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.9 t -69.05 21.65 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -63.04 132.31 51.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.113 2.165 . . . . 0.0 111.346 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -62.14 -15.84 48.59 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.476 -1.726 . . . . 0.0 113.398 168.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.0 120.55 16.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 121.515 1.961 . . . . 0.0 113.186 -172.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.37 153.8 41.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.123 2.169 . . . . 0.0 113.644 162.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -72.42 134.1 82.57 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-O 117.385 -1.293 . . . . 0.0 111.856 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 N--CA 1.45 -1.072 0 C-N-CA 122.573 2.182 . . . . 0.0 110.08 175.905 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.439 0 CA-C-O 117.433 -1.76 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.34 6.3 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 119.093 1.447 . . . . 0.0 114.585 -170.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.71 -155.38 25.34 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 125.811 1.672 . . . . 0.0 109.486 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.96 150.56 39.04 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 120.694 2.247 . . . . 0.0 114.92 171.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.66 -125.35 2.97 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.999 1.761 . . . . 0.0 115.532 -170.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.43 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -59.53 164.97 4.59 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 128.216 2.606 . . . . 0.0 113.929 171.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 6' ' ' ARG . 63.1 Cg_endo -71.49 155.34 59.76 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.833 3.689 . . . . 0.0 110.511 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.72 136.85 56.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.838 -1.164 . . . . 0.0 112.381 -173.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.2 p -64.48 -31.28 72.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.876 1.671 . . . . 0.0 115.026 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.5 pt -132.23 -13.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.1 mt -105.9 159.08 16.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.589 -1.319 . . . . 0.0 110.676 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -82.9 65.11 7.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.562 -1.336 . . . . 0.0 109.455 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -137.34 159.84 40.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.393 1.477 . . . . 0.0 110.567 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -105.65 -9.44 17.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.565 1.166 . . . . 0.0 111.623 -166.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -128.17 118.23 23.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.724 1.147 . . . . 0.0 112.054 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.0 150.79 37.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 129.096 2.958 . . . . 0.0 112.308 164.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HE2' ' HD2' ' A' ' 18' ' ' PRO . 3.0 mmpt? -74.42 171.88 10.17 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 120.61 -1.306 . . . . 0.0 110.909 163.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.449 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 59.0 Cg_endo . . . . . 0 N--CA 1.449 -1.138 0 CA-C-N 120.766 1.309 . . . . 0.0 111.275 150.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 CA-C-O 118.687 -1.063 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.23 116.09 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 126.515 1.926 . . . . 0.0 110.824 -177.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.83 -146.03 24.01 Favored Glycine 0 CA--C 1.523 0.546 0 O-C-N 119.918 -1.738 . . . . 0.0 113.095 -168.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -145.28 166.73 24.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.516 1.526 . . . . 0.0 110.145 174.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.99 -86.67 0.23 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.942 1.258 . . . . 0.0 115.075 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -122.39 173.52 4.11 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 127.683 2.393 . . . . 0.0 111.52 -174.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -48.97 154.07 3.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 124.042 3.162 . . . . 0.0 117.625 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -107.87 128.58 54.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.571 1.548 . . . . 0.0 109.358 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 p -69.89 -52.25 26.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -171.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.7 mt -99.29 -65.5 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.532 0.733 . . . . 0.0 110.056 -173.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.61 118.9 7.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.604 -1.31 . . . . 0.0 113.788 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -72.68 77.72 1.1 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.626 2.371 . . . . 0.0 110.873 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.44 172.88 12.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.38 2.272 . . . . 0.0 108.12 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -59.08 -67.6 0.35 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.429 1.491 . . . . 0.0 113.627 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -136.7 170.66 15.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.068 2.147 . . . . 0.0 111.125 -172.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.36 171.12 14.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 129.99 3.316 . . . . 0.0 109.012 167.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -66.28 167.01 13.74 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 120.99 -1.069 . . . . 0.0 108.896 159.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo . . . . . 0 N--CA 1.449 -1.12 0 CA-C-N 121.554 1.591 . . . . 0.0 111.072 158.075 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 119.251 -0.75 . . . . 0.0 114.687 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.93 140.54 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 118.194 0.997 . . . . 0.0 109.997 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.98 -164.66 53.1 Favored Glycine 0 CA--C 1.523 0.55 0 O-C-N 120.595 -1.316 . . . . 0.0 113.445 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -142.15 165.31 27.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.521 -0.987 . . . . 0.0 112.413 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.48 -26.74 3.31 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 128.562 2.982 . . . . 0.0 114.196 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.431 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 9.3 ptm180 -150.51 174.53 3.44 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 127.035 2.134 . . . . 0.0 110.546 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 6' ' ' ARG . 60.2 Cg_endo -72.15 159.29 50.22 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.712 2.275 . . . . 0.0 111.161 169.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -84.56 154.47 22.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.952 1.701 . . . . 0.0 112.684 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.1 p -124.4 -2.78 7.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.861 2.064 . . . . 0.0 114.908 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.2 mt -123.72 -43.12 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.846 2.058 . . . . 0.0 110.16 -170.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.8 mt -112.33 154.07 26.26 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.595 1.158 . . . . 0.0 111.201 169.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.1 m -69.96 87.1 0.54 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.28 1.032 . . . . 0.0 108.866 172.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -143.03 152.52 41.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.465 1.106 . . . . 0.0 110.931 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -79.62 -11.19 59.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -133.38 134.54 43.84 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.096 2.158 . . . . 0.0 111.707 -170.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.19 163.13 36.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.478 1.111 . . . . 0.0 110.699 155.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -87.83 145.58 37.06 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 127.326 2.251 . . . . 0.0 110.198 155.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.449 -1.143 0 CA-C-N 121.443 1.551 . . . . 0.0 111.423 168.239 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.507 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.03 133.43 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 118.25 1.025 . . . . 0.0 111.216 163.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.72 -159.71 7.09 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 125.195 1.378 . . . . 0.0 115.584 -170.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -141.28 169.73 17.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.219 1.408 . . . . 0.0 113.006 173.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.23 -154.92 16.66 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 128.086 2.755 . . . . 0.0 111.629 -154.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -34.42 138.57 0.32 Allowed Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 128.3 2.64 . . . . 0.0 115.789 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.6 146.4 43.65 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.117 2.545 . . . . 0.0 115.664 -170.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -68.51 133.41 48.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.789 1.236 . . . . 0.0 111.333 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 m -118.41 16.09 13.85 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.407 1.483 . . . . 0.0 113.856 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.1 mt -118.31 -63.21 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 128.565 2.746 . . . . 0.0 108.16 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -87.27 166.63 14.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.279 1.832 . . . . 0.0 109.432 173.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -77.98 82.37 4.34 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.204 1.401 . . . . 0.0 110.586 161.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -142.41 144.04 32.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.794 1.238 . . . . 0.0 112.629 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.42 -6.82 59.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -146.25 137.87 24.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.544 -1.217 . . . . 0.0 109.731 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.03 165.67 33.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.461 1.504 . . . . 0.0 113.652 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -59.95 134.66 90.05 Favored Pre-proline 0 N--CA 1.449 -0.524 0 O-C-N 119.719 -1.863 . . . . 0.0 111.193 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 N--CA 1.45 -1.056 0 C-N-CA 122.574 2.183 . . . . 0.0 109.839 168.065 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.55 0 CA-C-O 122.344 0.969 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.21 136.26 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 O-C-N 119.655 -2.085 . . . . 0.0 112.554 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.11 -154.27 27.53 Favored Glycine 0 CA--C 1.522 0.504 0 O-C-N 120.54 -1.35 . . . . 0.0 114.735 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -145.59 168.66 20.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.173 -0.604 . . . . 0.0 110.929 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.18 -19.45 17.55 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 118.177 2.031 . . . . 0.0 118.177 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -139.48 171.09 8.54 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 126.978 2.111 . . . . 0.0 108.143 171.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.39 152.84 75.15 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 CA-C-N 122.768 2.024 . . . . 0.0 113.288 168.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -71.93 162.11 29.95 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.034 -1.666 . . . . 0.0 112.479 165.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -103.33 -21.22 13.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.221 2.208 . . . . 0.0 115.769 170.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.7 mt -135.77 118.67 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.845 1.658 . . . . 0.0 109.312 -159.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.4 tp 70.26 142.27 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 129.67 3.188 . . . . 0.0 111.77 -170.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 m -60.85 88.87 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.619 1.168 . . . . 0.0 112.212 171.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -134.66 171.82 13.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.726 2.411 . . . . 0.0 110.956 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -78.65 -158.17 0.13 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 118.204 -2.81 . . . . 0.0 111.185 170.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -48.83 158.82 0.29 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.738 2.415 . . . . 0.0 115.772 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.65 -178.53 5.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.765 2.826 . . . . 0.0 112.466 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -135.85 151.42 74.01 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 130.22 3.408 . . . . 0.0 108.623 168.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.449 -1.136 0 C-N-CA 122.079 1.853 . . . . 0.0 113.19 170.649 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.539 0 CA-C-O 122.056 0.809 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.61 80.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.169 2.588 . . . . 0.0 109.892 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 113.26 -135.92 13.0 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 127.689 2.566 . . . . 0.0 114.682 168.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -144.99 149.42 35.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.374 1.087 . . . . 0.0 109.615 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.75 -62.14 0.48 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 125.262 1.411 . . . . 0.0 114.565 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.98 156.71 68.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 112.424 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.43 136.53 74.97 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.162 1.908 . . . . 0.0 111.952 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -64.13 146.87 53.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.735 2.014 . . . . 0.0 110.597 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.2 m -112.02 -10.09 13.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 mt -73.49 -60.95 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 119.997 1.271 . . . . 0.0 110.776 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.6 mt -125.94 171.06 11.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.368 1.467 . . . . 0.0 111.103 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -74.87 83.5 2.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.464 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -124.45 123.1 39.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.281 1.832 . . . . 0.0 108.656 166.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -57.18 -21.92 36.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.78 1.632 . . . . 0.0 113.164 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -132.99 118.16 18.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.787 2.035 . . . . 0.0 110.23 -163.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.81 154.73 40.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.461 2.305 . . . . 0.0 110.311 168.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -66.41 158.25 78.88 Favored Pre-proline 0 N--CA 1.45 -0.451 0 O-C-N 120.897 -1.127 . . . . 0.0 111.897 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 N--CA 1.45 -1.045 0 C-N-CA 122.413 2.076 . . . . 0.0 110.367 145.213 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.491 0 N-CA-C 117.856 1.902 . . . . 0.0 117.856 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.5 p -141.03 135.97 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 120.778 -1.425 . . . . 0.0 112.529 174.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 61.02 -110.6 3.16 Favored Glycine 0 CA--C 1.522 0.5 0 O-C-N 120.095 -1.628 . . . . 0.0 115.544 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -136.39 150.79 48.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.153 2.181 . . . . 0.0 113.153 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.36 -145.2 13.39 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.526 1.536 . . . . 0.0 115.116 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -58.68 175.76 0.3 Allowed Pre-proline 0 N--CA 1.449 -0.486 1 C-N-CA 132.692 4.397 . . . . 0.0 115.143 173.077 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 6' ' ' ARG . 55.4 Cg_endo -74.02 106.67 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.232 3.288 . . . . 0.0 113.464 165.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -74.21 101.8 4.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.798 1.239 . . . . 0.0 109.751 174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 m -76.78 28.57 0.13 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.383 2.673 . . . . 0.0 113.865 -168.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.66 -60.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.697 2.399 . . . . 0.0 108.163 168.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.59 89.69 3.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.414 1.486 . . . . 0.0 109.796 170.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -81.67 67.97 7.84 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.56 1.144 . . . . 0.0 112.359 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -77.94 66.32 3.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 123.863 1.792 . . . . 0.0 112.071 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 46.59 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.346 3.059 . . . . 0.0 113.75 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -100.04 117.89 35.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.27 146.47 29.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.786 1.279 . . . . 0.0 113.378 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -75.92 147.11 80.26 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 128.392 2.677 . . . . 0.0 110.601 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo . . . . . 0 N--CA 1.45 -1.075 0 C-N-CA 121.653 1.569 . . . . 0.0 112.335 175.343 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.07 152.88 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.38 1.872 . . . . 0.0 110.027 150.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.1 -137.49 31.67 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 119.957 1.253 . . . . 0.0 113.489 173.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -140.47 146.09 37.77 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.346 1.858 . . . . 0.0 114.32 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.8 -86.49 0.14 Allowed Glycine 0 C--N 1.336 0.547 0 O-C-N 121.467 -0.771 . . . . 0.0 114.043 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 161.59 45.4 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 128.595 2.758 . . . . 0.0 112.542 -172.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.96 124.46 13.57 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 CA-C-N 122.514 1.933 . . . . 0.0 110.911 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -58.23 114.62 2.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.151 1.381 . . . . 0.0 113.781 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.0 m -63.01 -24.88 68.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.2 mt -85.21 -55.17 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 119.711 1.141 . . . . 0.0 108.709 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -138.09 112.62 8.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 116.831 -1.557 . . . . 0.0 108.412 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -65.0 77.03 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -162.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -75.48 139.51 42.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 112.693 -2.049 . . . . 0.0 112.649 159.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -70.24 121.68 18.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.85 0.833 . . . . 0.0 111.845 170.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 59.06 104.47 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.689 2.396 . . . . 0.0 115.782 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.15 146.41 42.74 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 129.334 3.054 . . . . 0.0 111.519 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -63.24 113.87 10.91 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 127.846 2.459 . . . . 0.0 110.179 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo . . . . . 0 N--CA 1.448 -1.151 0 C-N-CA 121.461 1.441 . . . . 0.0 111.618 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.475 0 N-CA-C 116.181 1.232 . . . . 0.0 116.181 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.46 100.02 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.69 1.996 . . . . 0.0 109.243 -170.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.87 -161.34 53.93 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.56 172.9 7.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.441 1.496 . . . . 0.0 112.563 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.34 -63.81 0.58 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 118.851 0.75 . . . . 0.0 114.086 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -134.28 174.31 4.81 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 129.471 3.108 . . . . 0.0 111.205 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -66.0 147.98 85.2 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 CA-C-N 124.023 2.473 . . . . 0.0 114.023 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -70.94 134.18 47.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.683 -1.261 . . . . 0.0 108.783 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.5 m -75.52 -39.67 58.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 119.834 -1.791 . . . . 0.0 114.992 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 mt -83.92 -71.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.082 1.753 . . . . 0.0 110.989 -172.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -138.71 143.97 39.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 122.312 1.053 . . . . 0.0 110.432 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.5 70.18 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.039 2.535 . . . . 0.0 114.118 -171.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.36 154.29 38.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 132.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.31 -42.75 92.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.638 -2.538 . . . . 0.0 113.303 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -135.73 169.06 18.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.425 1.49 . . . . 0.0 114.525 -175.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.37 156.8 32.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 130.105 3.362 . . . . 0.0 111.622 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -69.83 157.58 89.33 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 125.931 1.692 . . . . 0.0 113.073 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.18 169.89 14.32 Favored 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 126.465 4.777 . . . . 0.0 110.381 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 76.5 mtp . . . . . 0 C--O 1.25 1.1 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -169.785 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 CA-C-O 121.734 0.63 . . . . 0.0 111.675 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.92 118.89 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.336 1.454 . . . . 0.0 110.366 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.1 -162.38 51.57 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 119.878 1.217 . . . . 0.0 111.562 -170.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -131.57 168.31 17.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 119.525 -2.162 . . . . 0.0 111.009 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.57 -77.43 0.31 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 127.163 2.316 . . . . 0.0 113.658 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.64 161.02 43.95 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.301 1.84 . . . . 0.0 114.798 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.03 119.48 6.71 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 CA-C-N 120.634 1.262 . . . . 0.0 113.34 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -54.07 117.64 3.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.261 2.224 . . . . 0.0 109.254 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -62.63 -9.6 9.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.2 mt -137.48 -64.06 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.917 1.687 . . . . 0.0 111.142 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.5 mt -92.9 160.92 14.69 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.335 1.454 . . . . 0.0 113.815 -167.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -83.14 72.48 10.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.819 1.248 . . . . 0.0 113.7 -165.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -144.41 159.09 43.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.029 0.919 . . . . 0.0 111.395 167.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.47 -32.61 72.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 116.754 -1.593 . . . . 0.0 114.732 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -140.06 156.33 46.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.91 158.88 44.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.317 3.047 . . . . 0.0 111.581 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -96.9 140.97 22.41 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 127.941 2.497 . . . . 0.0 110.561 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -58.19 148.74 76.7 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.322 2.015 . . . . 0.0 113.36 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 97.6 mtp . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.629 -1.177 . . . . 0.0 113.296 -160.785 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.767 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.0 p -148.15 155.9 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.137 2.175 . . . . 0.0 107.108 161.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 54.06 -139.39 37.26 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 121.636 2.016 . . . . 0.0 113.582 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.99 146.8 49.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.727 1.611 . . . . 0.0 113.618 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.43 -78.54 0.08 OUTLIER Glycine 0 C--N 1.335 0.497 0 N-CA-C 116.906 1.523 . . . . 0.0 116.906 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -145.68 172.67 5.03 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 129.633 3.173 . . . . 0.0 111.782 -168.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.08 100.68 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.309 2.006 . . . . 0.0 111.216 169.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . 29.2 t0 -81.04 74.66 8.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.357 1.463 . . . . 0.0 110.329 173.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -56.5 -7.72 0.44 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -159.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.0 mt -52.57 -46.05 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 127.395 2.278 . . . . 0.0 111.531 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tt -134.79 139.48 45.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.357 1.863 . . . . 0.0 110.216 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -72.49 80.19 1.06 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.457 1.103 . . . . 0.0 111.317 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -137.54 165.48 26.2 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.614 1.166 . . . . 0.0 110.436 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.04 155.23 40.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.469 1.108 . . . . 0.0 112.668 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 29.21 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.16 3.784 . . . . 0.0 113.42 147.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 8' ' ' ASP . . . -136.25 146.63 46.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.59 2.356 . . . . 0.0 110.315 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -59.96 155.41 43.28 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 126.7 2.0 . . . . 0.0 112.421 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.8 163.78 8.75 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.154 2.57 . . . . 0.0 112.512 157.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 C--O 1.25 1.1 0 C-N-CA 123.732 0.813 . . . . 0.0 112.026 -164.914 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.504 0 CA-C-O 117.512 -1.715 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -152.59 152.49 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.848 2.059 . . . . 0.0 109.415 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.57 -160.99 43.36 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 119.183 0.901 . . . . 0.0 114.312 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.71 164.28 28.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.594 -1.533 . . . . 0.0 114.719 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.72 -154.76 19.34 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 124.735 1.159 . . . . 0.0 111.306 -158.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -50.51 150.32 4.89 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 126.876 2.07 . . . . 0.0 113.076 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.65 145.06 96.96 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.864 3.043 . . . . 0.0 113.788 -168.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -68.6 139.29 55.53 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.626 -1.296 . . . . 0.0 109.489 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -71.77 -79.36 0.07 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -75.03 -74.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.609 1.164 . . . . 0.0 112.015 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 tp -60.06 117.99 5.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.862 -1.774 . . . . 0.0 109.053 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -69.3 71.9 0.29 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.522 1.529 . . . . 0.0 112.984 -171.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -108.52 135.48 49.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.784 1.634 . . . . 0.0 107.705 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -56.16 -38.14 70.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.506 -1.371 . . . . 0.0 113.359 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -131.43 153.52 49.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.297 1.439 . . . . 0.0 108.508 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.82 153.15 42.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.471 1.908 . . . . 0.0 113.324 172.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -61.93 141.91 95.32 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.851 169.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.7 115.07 3.55 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.286 2.658 . . . . 0.0 110.085 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 62.4 mtm . . . . . 0 C--O 1.251 1.154 0 C-N-CA 127.536 2.334 . . . . 0.0 110.495 -178.04 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.47 112.26 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.237 2.215 . . . . 0.0 108.233 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.6 -163.38 27.27 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 126.6 2.048 . . . . 0.0 114.97 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -117.01 155.1 29.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.523 1.129 . . . . 0.0 112.106 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.04 -137.18 9.59 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 127.187 2.327 . . . . 0.0 114.202 -169.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -63.1 150.89 87.64 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 128.071 2.549 . . . . 0.0 111.996 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -62.62 147.94 94.06 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.862 3.041 . . . . 0.0 112.985 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -96.82 87.01 4.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.231 -1.35 . . . . 0.0 113.052 -162.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -50.74 -30.22 13.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.2 mt -68.69 -26.51 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.425 1.49 . . . . 0.0 110.04 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.77 -152.03 0.49 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.135 2.174 . . . . 0.0 108.169 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -130.48 89.83 2.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.508 -1.37 . . . . 0.0 110.694 160.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -138.26 155.28 48.77 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.29 1.836 . . . . 0.0 110.361 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -56.58 -38.62 72.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.479 1.112 . . . . 0.0 113.782 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -141.63 153.56 44.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.43 154.81 40.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.724 3.21 . . . . 0.0 110.802 157.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -76.06 151.49 83.98 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 116.662 -1.637 . . . . 0.0 108.454 159.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.2 162.37 30.18 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.078 2.519 . . . . 0.0 109.103 167.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.1 ptm . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.761 2.025 . . . . 0.0 115.311 -172.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 112.936 -0.065 . . . . 0.0 112.936 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 p -149.4 95.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.996 2.118 . . . . 0.0 113.603 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.07 -124.11 19.36 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 124.984 1.278 . . . . 0.0 112.034 -174.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.96 163.55 39.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.967 1.707 . . . . 0.0 114.023 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.37 -52.19 0.49 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 128.005 2.716 . . . . 0.0 113.114 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -139.88 175.39 3.23 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 131.421 3.888 . . . . 0.0 109.626 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.79 163.71 38.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 CA-C-N 124.869 2.775 . . . . 0.0 112.896 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -78.3 99.98 6.53 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 171.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 m -65.12 -15.36 62.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.49 -46.0 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.403 1.081 . . . . 0.0 112.616 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 tt -153.64 114.77 4.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.797 2.039 . . . . 0.0 109.707 173.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -63.9 109.2 1.69 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.002 0.921 . . . . 0.0 112.03 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -134.0 -81.46 0.46 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 165.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -123.13 -174.46 2.95 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.739 2.416 . . . . 0.0 111.146 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -66.28 166.07 12.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.45 178.95 9.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.494 2.718 . . . . 0.0 111.921 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -105.32 170.01 6.42 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 126.944 2.098 . . . . 0.0 111.6 161.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -77.67 -175.02 2.46 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.967 2.445 . . . . 0.0 111.973 167.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 48.6 ttp . . . . . 0 C--O 1.251 1.159 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.538 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 117.524 -1.709 . . . . 0.0 114.298 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 p -116.93 129.3 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 120.239 2.019 . . . . 0.0 110.453 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.87 -155.75 39.33 Favored Glycine 0 C--N 1.335 0.52 0 O-C-N 120.799 -1.188 . . . . 0.0 113.214 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.269 0.3 OUTLIER -134.38 165.53 24.93 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 120.369 -1.665 . . . . 0.0 113.638 175.239 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.37 -153.19 17.59 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 126.166 1.841 . . . . 0.0 110.961 -159.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.22 148.46 3.16 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 127.205 2.202 . . . . 0.0 114.703 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.77 149.05 72.63 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.854 3.036 . . . . 0.0 111.986 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -93.05 160.31 14.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 119.517 -1.989 . . . . 0.0 113.839 -160.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.0 m -97.95 -32.2 11.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -161.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -116.53 -69.25 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.215 1.406 . . . . 0.0 110.187 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.4 mm? -66.88 119.65 12.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.849 1.259 . . . . 0.0 109.842 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.9 m -47.91 108.53 0.17 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.633 1.573 . . . . 0.0 112.073 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -156.48 144.38 19.47 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.638 -1.289 . . . . 0.0 113.855 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.44 -31.89 73.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 165.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -144.12 149.69 36.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 125.192 1.558 . . . . 0.0 113.882 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.7 161.78 34.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.086 2.555 . . . . 0.0 112.138 171.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 7.1 mmpt? -58.33 145.91 73.3 Favored Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 120.524 -1.36 . . . . 0.0 113.186 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.28 134.14 28.23 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 160.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.9 ttm . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.699 1.599 . . . . 0.0 112.67 -170.329 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.15 141.1 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 120.458 2.129 . . . . 0.0 111.325 159.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.22 -165.4 54.61 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 119.147 0.885 . . . . 0.0 112.981 -165.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -136.16 142.43 44.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.299 -1.118 . . . . 0.0 111.601 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.9 -113.16 0.55 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 126.156 1.836 . . . . 0.0 110.663 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.9 ptt85 -64.9 168.84 6.33 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 120.687 2.244 . . . . 0.0 112.719 168.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.82 161.38 39.5 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 CA-C-N 120.725 1.295 . . . . 0.0 113.523 163.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.62 158.78 30.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 119.42 -2.05 . . . . 0.0 112.029 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.8 m -83.94 -28.03 28.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.874 2.47 . . . . 0.0 114.377 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.7 mt -107.54 -79.95 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.564 1.546 . . . . 0.0 111.107 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.96 137.95 16.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.274 1.829 . . . . 0.0 109.701 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.283 12.4 t -71.61 74.44 0.8 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.235 1.014 . . . . 0.0 109.576 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -139.52 150.29 44.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 119.377 -2.077 . . . . 0.0 112.257 -166.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -86.37 -18.36 32.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.113 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -129.3 116.53 19.25 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.181 1.392 . . . . 0.0 112.872 -166.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.84 127.82 15.52 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.567 2.347 . . . . 0.0 109.659 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -77.43 124.88 86.82 Favored Pre-proline 0 N--CA 1.449 -0.505 0 O-C-N 119.281 -2.137 . . . . 0.0 108.269 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -60.82 165.48 11.82 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.469 2.78 . . . . 0.0 115.802 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 C--O 1.25 1.096 0 CA-C-O 116.254 -1.831 . . . . 0.0 111.143 -170.086 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 CA-C-O 119.534 -0.592 . . . . 0.0 112.84 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.61 65.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.741 1.216 . . . . 0.0 110.441 -162.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.99 177.86 37.05 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 127.895 2.664 . . . . 0.0 114.927 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -64.22 141.73 58.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 119.969 -1.901 . . . . 0.0 115.015 -169.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.93 -144.02 11.28 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.391 1.472 . . . . 0.0 112.792 -173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 164.88 12.82 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 125.765 1.626 . . . . 0.0 113.696 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -60.45 135.77 63.36 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 CA-C-N 122.759 2.021 . . . . 0.0 111.509 166.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -88.21 93.09 9.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.879 0.847 . . . . 0.0 110.886 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -67.81 -22.69 65.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.3 mt -79.66 -49.41 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.28 1.032 . . . . 0.0 112.931 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.4 116.5 16.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.824 1.649 . . . . 0.0 108.097 -174.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.8 m -48.78 95.63 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.577 2.351 . . . . 0.0 115.576 -166.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -150.83 163.85 37.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 129.367 3.067 . . . . 0.0 109.363 160.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.03 10.87 10.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.544 -1.348 . . . . 0.0 114.574 166.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -144.72 122.95 12.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.378 1.871 . . . . 0.0 114.175 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.43 133.43 25.83 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.907 2.883 . . . . 0.0 112.068 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -46.2 115.64 3.14 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 126.472 1.909 . . . . 0.0 110.577 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -64.91 119.95 7.09 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 124.418 3.412 . . . . 0.0 111.278 -166.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.2 ttp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 128.389 2.676 . . . . 0.0 111.327 177.399 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 117.623 1.809 . . . . 0.0 117.623 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.53 169.73 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 126.984 2.114 . . . . 0.0 108.36 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.84 -143.54 45.17 Favored Glycine 0 CA--C 1.522 0.511 0 O-C-N 119.61 -1.932 . . . . 0.0 113.594 161.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.7 161.05 38.9 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.414 1.086 . . . . 0.0 113.417 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.14 -78.18 0.21 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 126.469 1.985 . . . . 0.0 112.97 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.71 167.14 23.41 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 130.253 3.421 . . . . 0.0 114.025 -167.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -70.73 113.09 3.42 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 CA-C-N 122.908 2.074 . . . . 0.0 115.523 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -68.63 105.39 2.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.371 1.468 . . . . 0.0 110.448 163.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -58.04 -19.11 28.95 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 117.678 2.473 . . . . 0.0 117.678 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.9 mm -94.98 -16.74 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.574 1.95 . . . . 0.0 108.821 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.2 tp -146.63 93.45 2.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 119.825 -1.797 . . . . 0.0 112.028 -168.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.0 p -64.23 16.25 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 119.563 3.172 . . . . 0.0 119.563 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -52.98 104.87 0.1 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.025 0.93 . . . . 0.0 111.361 159.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.4 138.17 56.49 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 124.149 0.906 . . . . 0.0 111.518 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 52.49 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.503 1.921 . . . . 0.0 112.223 -157.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.1 -170.14 2.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.258 1.823 . . . . 0.0 111.667 170.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -148.27 135.74 10.73 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 126.85 2.06 . . . . 0.0 108.342 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -62.57 172.46 4.48 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.373 2.049 . . . . 0.0 110.195 171.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 C--O 1.25 1.086 0 CA-C-N 113.64 -1.618 . . . . 0.0 114.768 -177.109 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.527 0 CA-C-O 118.184 -1.342 . . . . 0.0 112.839 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.46 114.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 128.996 2.919 . . . . 0.0 110.841 168.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.11 -153.16 52.86 Favored Glycine 0 N--CA 1.448 -0.546 0 O-C-N 121.098 -1.001 . . . . 0.0 111.84 -170.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.03 166.92 23.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.83 -87.91 0.2 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 125.769 1.652 . . . . 0.0 110.804 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -76.42 168.27 29.49 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 124.889 1.275 . . . . 0.0 109.816 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -67.93 151.66 77.78 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 CA-C-N 121.379 1.528 . . . . 0.0 112.828 161.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -82.41 122.53 28.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.037 -1.039 . . . . 0.0 110.211 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 m -59.19 -12.37 5.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mt -120.23 140.26 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.55 98.22 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.96 1.704 . . . . 0.0 110.293 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -151.29 -67.48 0.18 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.417 -0.802 . . . . 0.0 110.061 -168.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -142.54 162.22 36.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.323 2.649 . . . . 0.0 109.214 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -54.7 -35.83 64.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.583 1.553 . . . . 0.0 114.454 -168.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -136.25 174.55 10.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.096 2.159 . . . . 0.0 111.811 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.66 162.09 39.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.195 -1.566 . . . . 0.0 109.863 167.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -66.71 172.52 3.23 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.231 1.012 . . . . 0.0 111.354 163.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.9 171.74 0.97 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 124.715 3.61 . . . . 0.0 114.994 157.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 17.2 ttt . . . . . 0 C--O 1.249 1.064 0 C-N-CA 127.36 2.264 . . . . 0.0 113.374 178.836 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.52 0 N-CA-C 118.052 1.981 . . . . 0.0 118.052 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.5 137.18 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.77 2.028 . . . . 0.0 110.971 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.34 -150.92 20.7 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.072 1.32 . . . . 0.0 116.162 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -145.36 151.47 38.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 119.478 1.639 . . . . 0.0 113.418 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.72 -114.69 0.8 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 126.779 2.133 . . . . 0.0 109.894 -165.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 160.72 78.09 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 127.861 2.464 . . . . 0.0 113.514 172.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.67 138.17 62.81 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 CA-C-N 121.057 1.413 . . . . 0.0 111.691 151.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.7 164.83 25.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.416 0.686 . . . . 0.0 111.871 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.8 m -77.32 -57.51 3.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.688 -0.633 . . . . 0.0 111.668 -169.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.8 mt -94.72 -63.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -166.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.23 130.34 42.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.178 1.391 . . . . 0.0 109.178 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.9 t -69.05 21.65 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -63.04 132.31 51.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.113 2.165 . . . . 0.0 111.346 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -62.14 -15.84 48.59 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.476 -1.726 . . . . 0.0 113.398 168.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.0 120.55 16.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 121.515 1.961 . . . . 0.0 113.186 -172.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.37 153.8 41.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.123 2.169 . . . . 0.0 113.644 162.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -72.42 134.1 82.57 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-O 117.385 -1.293 . . . . 0.0 111.856 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.7 88.48 1.04 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.573 2.182 . . . . 0.0 110.08 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 40.6 mmm . . . . . 0 C--O 1.25 1.117 0 C-N-CA 129.953 3.301 . . . . 0.0 115.161 178.173 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.439 0 CA-C-O 117.433 -1.76 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.34 6.3 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 119.093 1.447 . . . . 0.0 114.585 -170.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.71 -155.38 25.34 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 125.811 1.672 . . . . 0.0 109.486 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.96 150.56 39.04 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 120.694 2.247 . . . . 0.0 114.92 171.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.66 -125.35 2.97 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.999 1.761 . . . . 0.0 115.532 -170.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.43 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -59.53 164.97 4.59 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 128.216 2.606 . . . . 0.0 113.929 171.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 6' ' ' ARG . 63.1 Cg_endo -71.49 155.34 59.76 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.833 3.689 . . . . 0.0 110.511 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.72 136.85 56.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.838 -1.164 . . . . 0.0 112.381 -173.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.2 p -64.48 -31.28 72.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.876 1.671 . . . . 0.0 115.026 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.5 pt -132.23 -13.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.1 mt -105.9 159.08 16.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.589 -1.319 . . . . 0.0 110.676 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -82.9 65.11 7.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.562 -1.336 . . . . 0.0 109.455 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -137.34 159.84 40.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.393 1.477 . . . . 0.0 110.567 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -105.65 -9.44 17.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.565 1.166 . . . . 0.0 111.623 -166.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -128.17 118.23 23.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.724 1.147 . . . . 0.0 112.054 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.0 150.79 37.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 129.096 2.958 . . . . 0.0 112.308 164.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HE2' ' HD2' ' A' ' 18' ' ' PRO . 3.0 mmpt? -74.42 171.88 10.17 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 120.61 -1.306 . . . . 0.0 110.909 163.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.449 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 59.0 Cg_endo -62.36 151.72 81.01 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 CA-C-N 120.766 1.309 . . . . 0.0 111.275 150.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.2 ttt . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.064 1.346 . . . . 0.0 112.467 177.298 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 CA-C-O 118.687 -1.063 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.23 116.09 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 126.515 1.926 . . . . 0.0 110.824 -177.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.83 -146.03 24.01 Favored Glycine 0 CA--C 1.523 0.546 0 O-C-N 119.918 -1.738 . . . . 0.0 113.095 -168.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -145.28 166.73 24.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.516 1.526 . . . . 0.0 110.145 174.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.99 -86.67 0.23 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.942 1.258 . . . . 0.0 115.075 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -122.39 173.52 4.11 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 127.683 2.393 . . . . 0.0 111.52 -174.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -48.97 154.07 3.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 124.042 3.162 . . . . 0.0 117.625 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -107.87 128.58 54.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.571 1.548 . . . . 0.0 109.358 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 p -69.89 -52.25 26.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -171.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.7 mt -99.29 -65.5 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.532 0.733 . . . . 0.0 110.056 -173.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.61 118.9 7.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.604 -1.31 . . . . 0.0 113.788 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -72.68 77.72 1.1 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.626 2.371 . . . . 0.0 110.873 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.44 172.88 12.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.38 2.272 . . . . 0.0 108.12 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -59.08 -67.6 0.35 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.429 1.491 . . . . 0.0 113.627 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -136.7 170.66 15.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.068 2.147 . . . . 0.0 111.125 -172.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.36 171.12 14.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 129.99 3.316 . . . . 0.0 109.012 167.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -66.28 167.01 13.74 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 120.99 -1.069 . . . . 0.0 108.896 159.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -59.32 148.76 84.9 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 CA-C-N 121.554 1.591 . . . . 0.0 111.072 158.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 53.2 mtm . . . . . 0 C--O 1.25 1.126 0 C-N-CA 125.93 1.692 . . . . 0.0 112.529 -163.263 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 119.251 -0.75 . . . . 0.0 114.687 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.93 140.54 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 118.194 0.997 . . . . 0.0 109.997 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.98 -164.66 53.1 Favored Glycine 0 CA--C 1.523 0.55 0 O-C-N 120.595 -1.316 . . . . 0.0 113.445 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -142.15 165.31 27.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.521 -0.987 . . . . 0.0 112.413 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.48 -26.74 3.31 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 128.562 2.982 . . . . 0.0 114.196 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.431 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 9.3 ptm180 -150.51 174.53 3.44 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 127.035 2.134 . . . . 0.0 110.546 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 6' ' ' ARG . 60.2 Cg_endo -72.15 159.29 50.22 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.712 2.275 . . . . 0.0 111.161 169.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -84.56 154.47 22.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.952 1.701 . . . . 0.0 112.684 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.1 p -124.4 -2.78 7.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.861 2.064 . . . . 0.0 114.908 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.2 mt -123.72 -43.12 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.846 2.058 . . . . 0.0 110.16 -170.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.8 mt -112.33 154.07 26.26 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.595 1.158 . . . . 0.0 111.201 169.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.1 m -69.96 87.1 0.54 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.28 1.032 . . . . 0.0 108.866 172.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -143.03 152.52 41.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.465 1.106 . . . . 0.0 110.931 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -79.62 -11.19 59.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -133.38 134.54 43.84 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.096 2.158 . . . . 0.0 111.707 -170.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.19 163.13 36.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.478 1.111 . . . . 0.0 110.699 155.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -87.83 145.58 37.06 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 127.326 2.251 . . . . 0.0 110.198 155.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.05 159.96 32.12 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 CA-C-N 121.443 1.551 . . . . 0.0 111.423 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.6 ttt . . . . . 0 C--O 1.25 1.11 0 C-N-CA 124.772 1.229 . . . . 0.0 111.325 163.71 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.507 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.03 133.43 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 118.25 1.025 . . . . 0.0 111.216 163.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.72 -159.71 7.09 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 125.195 1.378 . . . . 0.0 115.584 -170.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -141.28 169.73 17.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.219 1.408 . . . . 0.0 113.006 173.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.23 -154.92 16.66 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 128.086 2.755 . . . . 0.0 111.629 -154.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -34.42 138.57 0.32 Allowed Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 128.3 2.64 . . . . 0.0 115.789 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.6 146.4 43.65 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.117 2.545 . . . . 0.0 115.664 -170.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -68.51 133.41 48.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.789 1.236 . . . . 0.0 111.333 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 m -118.41 16.09 13.85 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.407 1.483 . . . . 0.0 113.856 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.1 mt -118.31 -63.21 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 128.565 2.746 . . . . 0.0 108.16 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -87.27 166.63 14.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.279 1.832 . . . . 0.0 109.432 173.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -77.98 82.37 4.34 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.204 1.401 . . . . 0.0 110.586 161.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -142.41 144.04 32.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.794 1.238 . . . . 0.0 112.629 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.42 -6.82 59.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -146.25 137.87 24.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.544 -1.217 . . . . 0.0 109.731 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.03 165.67 33.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.461 1.504 . . . . 0.0 113.652 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -59.95 134.66 90.05 Favored Pre-proline 0 N--CA 1.449 -0.524 0 O-C-N 119.719 -1.863 . . . . 0.0 111.193 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -66.15 143.5 71.66 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.574 2.183 . . . . 0.0 109.839 168.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 56.5 ttm . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.382 1.473 . . . . 0.0 111.33 -178.224 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.55 0 CA-C-O 122.344 0.969 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.21 136.26 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 O-C-N 119.655 -2.085 . . . . 0.0 112.554 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.11 -154.27 27.53 Favored Glycine 0 CA--C 1.522 0.504 0 O-C-N 120.54 -1.35 . . . . 0.0 114.735 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -145.59 168.66 20.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.173 -0.604 . . . . 0.0 110.929 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.18 -19.45 17.55 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 118.177 2.031 . . . . 0.0 118.177 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -139.48 171.09 8.54 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 126.978 2.111 . . . . 0.0 108.143 171.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.39 152.84 75.15 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 CA-C-N 122.768 2.024 . . . . 0.0 113.288 168.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -71.93 162.11 29.95 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.034 -1.666 . . . . 0.0 112.479 165.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -103.33 -21.22 13.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.221 2.208 . . . . 0.0 115.769 170.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.7 mt -135.77 118.67 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.845 1.658 . . . . 0.0 109.312 -159.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.4 tp 70.26 142.27 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 129.67 3.188 . . . . 0.0 111.77 -170.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 m -60.85 88.87 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.619 1.168 . . . . 0.0 112.212 171.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -134.66 171.82 13.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.726 2.411 . . . . 0.0 110.956 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -78.65 -158.17 0.13 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 118.204 -2.81 . . . . 0.0 111.185 170.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -48.83 158.82 0.29 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.738 2.415 . . . . 0.0 115.772 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.65 -178.53 5.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.765 2.826 . . . . 0.0 112.466 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -135.85 151.42 74.01 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 130.22 3.408 . . . . 0.0 108.623 168.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -63.75 174.46 3.72 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.079 1.853 . . . . 0.0 113.19 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.7 ptm . . . . . 0 C--O 1.25 1.12 0 C-N-CA 127.578 2.351 . . . . 0.0 116.678 179.544 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.539 0 CA-C-O 122.056 0.809 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.61 80.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.169 2.588 . . . . 0.0 109.892 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 113.26 -135.92 13.0 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 127.689 2.566 . . . . 0.0 114.682 168.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -144.99 149.42 35.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.374 1.087 . . . . 0.0 109.615 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.75 -62.14 0.48 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 125.262 1.411 . . . . 0.0 114.565 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.98 156.71 68.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 112.424 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.43 136.53 74.97 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.162 1.908 . . . . 0.0 111.952 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -64.13 146.87 53.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.735 2.014 . . . . 0.0 110.597 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.2 m -112.02 -10.09 13.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 mt -73.49 -60.95 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 119.997 1.271 . . . . 0.0 110.776 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.6 mt -125.94 171.06 11.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.368 1.467 . . . . 0.0 111.103 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -74.87 83.5 2.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.464 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -124.45 123.1 39.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.281 1.832 . . . . 0.0 108.656 166.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -57.18 -21.92 36.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.78 1.632 . . . . 0.0 113.164 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -132.99 118.16 18.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.787 2.035 . . . . 0.0 110.23 -163.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.81 154.73 40.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.461 2.305 . . . . 0.0 110.311 168.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -66.41 158.25 78.88 Favored Pre-proline 0 N--CA 1.45 -0.451 0 O-C-N 120.897 -1.127 . . . . 0.0 111.897 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.65 101.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.413 2.076 . . . . 0.0 110.367 145.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 30.7 tpp . . . . . 0 C--O 1.25 1.118 0 C-N-CA 127.859 2.464 . . . . 0.0 112.15 -169.311 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.491 0 N-CA-C 117.856 1.902 . . . . 0.0 117.856 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.5 p -141.03 135.97 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 120.778 -1.425 . . . . 0.0 112.529 174.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 61.02 -110.6 3.16 Favored Glycine 0 CA--C 1.522 0.5 0 O-C-N 120.095 -1.628 . . . . 0.0 115.544 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -136.39 150.79 48.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.153 2.181 . . . . 0.0 113.153 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.36 -145.2 13.39 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.526 1.536 . . . . 0.0 115.116 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -58.68 175.76 0.3 Allowed Pre-proline 0 N--CA 1.449 -0.486 1 C-N-CA 132.692 4.397 . . . . 0.0 115.143 173.077 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 6' ' ' ARG . 55.4 Cg_endo -74.02 106.67 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.232 3.288 . . . . 0.0 113.464 165.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -74.21 101.8 4.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.798 1.239 . . . . 0.0 109.751 174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 m -76.78 28.57 0.13 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.383 2.673 . . . . 0.0 113.865 -168.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.66 -60.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.697 2.399 . . . . 0.0 108.163 168.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.59 89.69 3.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.414 1.486 . . . . 0.0 109.796 170.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -81.67 67.97 7.84 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.56 1.144 . . . . 0.0 112.359 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -77.94 66.32 3.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 123.863 1.792 . . . . 0.0 112.071 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 46.59 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.346 3.059 . . . . 0.0 113.75 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -100.04 117.89 35.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.27 146.47 29.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.786 1.279 . . . . 0.0 113.378 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -75.92 147.11 80.26 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 128.392 2.677 . . . . 0.0 110.601 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.25 143.03 69.19 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.653 1.569 . . . . 0.0 112.335 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 71.1 mmm . . . . . 0 C--O 1.25 1.107 0 C-N-CA 126.283 1.833 . . . . 0.0 112.666 173.918 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.07 152.88 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.38 1.872 . . . . 0.0 110.027 150.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.1 -137.49 31.67 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 119.957 1.253 . . . . 0.0 113.489 173.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -140.47 146.09 37.77 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.346 1.858 . . . . 0.0 114.32 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.8 -86.49 0.14 Allowed Glycine 0 C--N 1.336 0.547 0 O-C-N 121.467 -0.771 . . . . 0.0 114.043 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 161.59 45.4 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 128.595 2.758 . . . . 0.0 112.542 -172.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.96 124.46 13.57 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 CA-C-N 122.514 1.933 . . . . 0.0 110.911 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -58.23 114.62 2.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.151 1.381 . . . . 0.0 113.781 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.0 m -63.01 -24.88 68.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.2 mt -85.21 -55.17 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 119.711 1.141 . . . . 0.0 108.709 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -138.09 112.62 8.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 116.831 -1.557 . . . . 0.0 108.412 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -65.0 77.03 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -162.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -75.48 139.51 42.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 112.693 -2.049 . . . . 0.0 112.649 159.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -70.24 121.68 18.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.85 0.833 . . . . 0.0 111.845 170.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 59.06 104.47 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.689 2.396 . . . . 0.0 115.782 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.15 146.41 42.74 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 129.334 3.054 . . . . 0.0 111.519 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -63.24 113.87 10.91 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 127.846 2.459 . . . . 0.0 110.179 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.99 153.75 76.75 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.461 1.441 . . . . 0.0 111.618 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 40.0 ttm . . . . . 0 C--O 1.25 1.104 0 C-N-CA 126.185 1.794 . . . . 0.0 112.761 175.634 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.475 0 N-CA-C 116.181 1.232 . . . . 0.0 116.181 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.46 100.02 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.69 1.996 . . . . 0.0 109.243 -170.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.87 -161.34 53.93 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.56 172.9 7.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.441 1.496 . . . . 0.0 112.563 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.34 -63.81 0.58 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 118.851 0.75 . . . . 0.0 114.086 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -134.28 174.31 4.81 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 129.471 3.108 . . . . 0.0 111.205 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -66.0 147.98 85.2 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 CA-C-N 124.023 2.473 . . . . 0.0 114.023 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -70.94 134.18 47.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.683 -1.261 . . . . 0.0 108.783 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.5 m -75.52 -39.67 58.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 119.834 -1.791 . . . . 0.0 114.992 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 mt -83.92 -71.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.082 1.753 . . . . 0.0 110.989 -172.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -138.71 143.97 39.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 122.312 1.053 . . . . 0.0 110.432 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.5 70.18 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.039 2.535 . . . . 0.0 114.118 -171.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.36 154.29 38.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 132.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.31 -42.75 92.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.638 -2.538 . . . . 0.0 113.303 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -135.73 169.06 18.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.425 1.49 . . . . 0.0 114.525 -175.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.37 156.8 32.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 130.105 3.362 . . . . 0.0 111.622 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -69.83 157.58 89.33 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 125.931 1.692 . . . . 0.0 113.073 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.448 -1.151 1 C-N-CA 126.465 4.777 . . . . 0.0 110.381 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 CA-C-O 121.734 0.63 . . . . 0.0 111.675 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.92 118.89 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.336 1.454 . . . . 0.0 110.366 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.1 -162.38 51.57 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 119.878 1.217 . . . . 0.0 111.562 -170.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -131.57 168.31 17.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 119.525 -2.162 . . . . 0.0 111.009 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.57 -77.43 0.31 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 127.163 2.316 . . . . 0.0 113.658 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.64 161.02 43.95 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.301 1.84 . . . . 0.0 114.798 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.03 119.48 6.71 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 CA-C-N 120.634 1.262 . . . . 0.0 113.34 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -54.07 117.64 3.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.261 2.224 . . . . 0.0 109.254 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -62.63 -9.6 9.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.2 mt -137.48 -64.06 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.917 1.687 . . . . 0.0 111.142 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.5 mt -92.9 160.92 14.69 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.335 1.454 . . . . 0.0 113.815 -167.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -83.14 72.48 10.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.819 1.248 . . . . 0.0 113.7 -165.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -144.41 159.09 43.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.029 0.919 . . . . 0.0 111.395 167.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.47 -32.61 72.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 116.754 -1.593 . . . . 0.0 114.732 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -140.06 156.33 46.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.91 158.88 44.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.317 3.047 . . . . 0.0 111.581 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -96.9 140.97 22.41 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 127.941 2.497 . . . . 0.0 110.561 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.448 -1.16 0 C-N-CA 122.322 2.015 . . . . 0.0 113.36 -179.37 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.767 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.0 p -148.15 155.9 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.137 2.175 . . . . 0.0 107.108 161.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 54.06 -139.39 37.26 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 121.636 2.016 . . . . 0.0 113.582 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.99 146.8 49.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.727 1.611 . . . . 0.0 113.618 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.43 -78.54 0.08 OUTLIER Glycine 0 C--N 1.335 0.497 0 N-CA-C 116.906 1.523 . . . . 0.0 116.906 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -145.68 172.67 5.03 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 129.633 3.173 . . . . 0.0 111.782 -168.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.08 100.68 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.309 2.006 . . . . 0.0 111.216 169.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . 29.2 t0 -81.04 74.66 8.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.357 1.463 . . . . 0.0 110.329 173.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -56.5 -7.72 0.44 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -159.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.0 mt -52.57 -46.05 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 127.395 2.278 . . . . 0.0 111.531 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tt -134.79 139.48 45.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.357 1.863 . . . . 0.0 110.216 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -72.49 80.19 1.06 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.457 1.103 . . . . 0.0 111.317 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -137.54 165.48 26.2 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.614 1.166 . . . . 0.0 110.436 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.04 155.23 40.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.469 1.108 . . . . 0.0 112.668 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 29.21 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.16 3.784 . . . . 0.0 113.42 147.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 8' ' ' ASP . . . -136.25 146.63 46.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.59 2.356 . . . . 0.0 110.315 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -59.96 155.41 43.28 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 126.7 2.0 . . . . 0.0 112.421 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo . . . . . 0 N--CA 1.45 -1.088 0 C-N-CA 123.154 2.57 . . . . 0.0 112.512 157.41 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.504 0 CA-C-O 117.512 -1.715 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -152.59 152.49 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.848 2.059 . . . . 0.0 109.415 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.57 -160.99 43.36 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 119.183 0.901 . . . . 0.0 114.312 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.71 164.28 28.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.594 -1.533 . . . . 0.0 114.719 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.72 -154.76 19.34 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 124.735 1.159 . . . . 0.0 111.306 -158.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -50.51 150.32 4.89 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 126.876 2.07 . . . . 0.0 113.076 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.65 145.06 96.96 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.864 3.043 . . . . 0.0 113.788 -168.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -68.6 139.29 55.53 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.626 -1.296 . . . . 0.0 109.489 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -71.77 -79.36 0.07 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -75.03 -74.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.609 1.164 . . . . 0.0 112.015 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 tp -60.06 117.99 5.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.862 -1.774 . . . . 0.0 109.053 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -69.3 71.9 0.29 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.522 1.529 . . . . 0.0 112.984 -171.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -108.52 135.48 49.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.784 1.634 . . . . 0.0 107.705 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -56.16 -38.14 70.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.506 -1.371 . . . . 0.0 113.359 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -131.43 153.52 49.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.297 1.439 . . . . 0.0 108.508 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.82 153.15 42.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.471 1.908 . . . . 0.0 113.324 172.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -61.93 141.91 95.32 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.851 169.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 N--CA 1.449 -1.094 0 C-N-CA 123.286 2.658 . . . . 0.0 110.085 177.609 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.47 112.26 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.237 2.215 . . . . 0.0 108.233 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.6 -163.38 27.27 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 126.6 2.048 . . . . 0.0 114.97 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -117.01 155.1 29.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.523 1.129 . . . . 0.0 112.106 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.472 ' H ' ' NE2' ' A' ' 15' ' ' GLN . . . 128.04 -137.18 9.59 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 127.187 2.327 . . . . 0.0 114.202 -169.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -63.1 150.89 87.64 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 128.071 2.549 . . . . 0.0 111.996 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -62.62 147.94 94.06 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.862 3.041 . . . . 0.0 112.985 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -96.82 87.01 4.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.231 -1.35 . . . . 0.0 113.052 -162.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -50.74 -30.22 13.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.2 mt -68.69 -26.51 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.425 1.49 . . . . 0.0 110.04 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.77 -152.03 0.49 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.135 2.174 . . . . 0.0 108.169 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -130.48 89.83 2.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.508 -1.37 . . . . 0.0 110.694 160.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -138.26 155.28 48.77 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.29 1.836 . . . . 0.0 110.361 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -56.58 -38.62 72.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.479 1.112 . . . . 0.0 113.782 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' NE2' ' H ' ' A' ' 5' ' ' GLY . 36.5 mt-30 -141.63 153.56 44.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.43 154.81 40.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.724 3.21 . . . . 0.0 110.802 157.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -76.06 151.49 83.98 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 116.662 -1.637 . . . . 0.0 108.454 159.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 N--CA 1.448 -1.15 0 C-N-CA 123.078 2.519 . . . . 0.0 109.103 167.517 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 112.936 -0.065 . . . . 0.0 112.936 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 p -149.4 95.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.996 2.118 . . . . 0.0 113.603 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.07 -124.11 19.36 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 124.984 1.278 . . . . 0.0 112.034 -174.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.96 163.55 39.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.967 1.707 . . . . 0.0 114.023 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.37 -52.19 0.49 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 128.005 2.716 . . . . 0.0 113.114 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -139.88 175.39 3.23 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 131.421 3.888 . . . . 0.0 109.626 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.79 163.71 38.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 CA-C-N 124.869 2.775 . . . . 0.0 112.896 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -78.3 99.98 6.53 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 171.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 m -65.12 -15.36 62.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.49 -46.0 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.403 1.081 . . . . 0.0 112.616 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 tt -153.64 114.77 4.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.797 2.039 . . . . 0.0 109.707 173.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -63.9 109.2 1.69 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.002 0.921 . . . . 0.0 112.03 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -134.0 -81.46 0.46 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 165.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -123.13 -174.46 2.95 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.739 2.416 . . . . 0.0 111.146 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -66.28 166.07 12.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.45 178.95 9.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.494 2.718 . . . . 0.0 111.921 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -105.32 170.01 6.42 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 126.944 2.098 . . . . 0.0 111.6 161.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.449 -1.124 0 C-N-CA 122.967 2.445 . . . . 0.0 111.973 167.494 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 117.524 -1.709 . . . . 0.0 114.298 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 p -116.93 129.3 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 120.239 2.019 . . . . 0.0 110.453 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.87 -155.75 39.33 Favored Glycine 0 C--N 1.335 0.52 0 O-C-N 120.799 -1.188 . . . . 0.0 113.214 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.269 0.3 OUTLIER -134.38 165.53 24.93 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 120.369 -1.665 . . . . 0.0 113.638 175.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.37 -153.19 17.59 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 126.166 1.841 . . . . 0.0 110.961 -159.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.22 148.46 3.16 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 127.205 2.202 . . . . 0.0 114.703 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.77 149.05 72.63 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.854 3.036 . . . . 0.0 111.986 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -93.05 160.31 14.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 119.517 -1.989 . . . . 0.0 113.839 -160.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.0 m -97.95 -32.2 11.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -161.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -116.53 -69.25 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.215 1.406 . . . . 0.0 110.187 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.4 mm? -66.88 119.65 12.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.849 1.259 . . . . 0.0 109.842 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.9 m -47.91 108.53 0.17 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.633 1.573 . . . . 0.0 112.073 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -156.48 144.38 19.47 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.638 -1.289 . . . . 0.0 113.855 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.44 -31.89 73.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 165.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -144.12 149.69 36.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 125.192 1.558 . . . . 0.0 113.882 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.7 161.78 34.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.086 2.555 . . . . 0.0 112.138 171.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 7.1 mmpt? -58.33 145.91 73.3 Favored Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 120.524 -1.36 . . . . 0.0 113.186 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo . . . . . 0 N--CA 1.45 -1.076 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 160.168 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.15 141.1 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 120.458 2.129 . . . . 0.0 111.325 159.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.22 -165.4 54.61 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 119.147 0.885 . . . . 0.0 112.981 -165.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -136.16 142.43 44.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.299 -1.118 . . . . 0.0 111.601 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.9 -113.16 0.55 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 126.156 1.836 . . . . 0.0 110.663 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.9 ptt85 -64.9 168.84 6.33 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 120.687 2.244 . . . . 0.0 112.719 168.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.82 161.38 39.5 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 CA-C-N 120.725 1.295 . . . . 0.0 113.523 163.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.62 158.78 30.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 119.42 -2.05 . . . . 0.0 112.029 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.8 m -83.94 -28.03 28.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.874 2.47 . . . . 0.0 114.377 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.7 mt -107.54 -79.95 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.564 1.546 . . . . 0.0 111.107 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.96 137.95 16.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.274 1.829 . . . . 0.0 109.701 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.283 12.4 t -71.61 74.44 0.8 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.235 1.014 . . . . 0.0 109.576 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -139.52 150.29 44.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 119.377 -2.077 . . . . 0.0 112.257 -166.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -86.37 -18.36 32.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.113 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -129.3 116.53 19.25 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.181 1.392 . . . . 0.0 112.872 -166.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.84 127.82 15.52 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.567 2.347 . . . . 0.0 109.659 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -77.43 124.88 86.82 Favored Pre-proline 0 N--CA 1.449 -0.505 0 O-C-N 119.281 -2.137 . . . . 0.0 108.269 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 0 N--CA 1.449 -1.129 0 C-N-CA 123.469 2.78 . . . . 0.0 115.802 -173.249 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 CA-C-O 119.534 -0.592 . . . . 0.0 112.84 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.61 65.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.741 1.216 . . . . 0.0 110.441 -162.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.99 177.86 37.05 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 127.895 2.664 . . . . 0.0 114.927 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -64.22 141.73 58.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 119.969 -1.901 . . . . 0.0 115.015 -169.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.93 -144.02 11.28 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.391 1.472 . . . . 0.0 112.792 -173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 164.88 12.82 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 125.765 1.626 . . . . 0.0 113.696 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -60.45 135.77 63.36 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 CA-C-N 122.759 2.021 . . . . 0.0 111.509 166.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -88.21 93.09 9.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.879 0.847 . . . . 0.0 110.886 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -67.81 -22.69 65.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.3 mt -79.66 -49.41 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.28 1.032 . . . . 0.0 112.931 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.4 116.5 16.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.824 1.649 . . . . 0.0 108.097 -174.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.8 m -48.78 95.63 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.577 2.351 . . . . 0.0 115.576 -166.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -150.83 163.85 37.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 129.367 3.067 . . . . 0.0 109.363 160.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.03 10.87 10.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.544 -1.348 . . . . 0.0 114.574 166.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -144.72 122.95 12.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.378 1.871 . . . . 0.0 114.175 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.43 133.43 25.83 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.907 2.883 . . . . 0.0 112.068 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -46.2 115.64 3.14 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 126.472 1.909 . . . . 0.0 110.577 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo . . . . . 0 N--CA 1.449 -1.123 0 C-N-CA 124.418 3.412 . . . . 0.0 111.278 -166.363 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 117.623 1.809 . . . . 0.0 117.623 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.53 169.73 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 126.984 2.114 . . . . 0.0 108.36 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.84 -143.54 45.17 Favored Glycine 0 CA--C 1.522 0.511 0 O-C-N 119.61 -1.932 . . . . 0.0 113.594 161.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.7 161.05 38.9 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.414 1.086 . . . . 0.0 113.417 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.14 -78.18 0.21 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 126.469 1.985 . . . . 0.0 112.97 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.71 167.14 23.41 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 130.253 3.421 . . . . 0.0 114.025 -167.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -70.73 113.09 3.42 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 CA-C-N 122.908 2.074 . . . . 0.0 115.523 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -68.63 105.39 2.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.371 1.468 . . . . 0.0 110.448 163.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -58.04 -19.11 28.95 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 117.678 2.473 . . . . 0.0 117.678 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.9 mm -94.98 -16.74 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.574 1.95 . . . . 0.0 108.821 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.2 tp -146.63 93.45 2.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 119.825 -1.797 . . . . 0.0 112.028 -168.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.0 p -64.23 16.25 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 119.563 3.172 . . . . 0.0 119.563 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -52.98 104.87 0.1 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.025 0.93 . . . . 0.0 111.361 159.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.4 138.17 56.49 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 124.149 0.906 . . . . 0.0 111.518 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.49 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.503 1.921 . . . . 0.0 112.223 -157.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.1 -170.14 2.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.258 1.823 . . . . 0.0 111.667 170.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -148.27 135.74 10.73 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 126.85 2.06 . . . . 0.0 108.342 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 N--CA 1.449 -1.14 0 C-N-CA 122.373 2.049 . . . . 0.0 110.195 171.416 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.527 0 CA-C-O 118.184 -1.342 . . . . 0.0 112.839 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.46 114.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 128.996 2.919 . . . . 0.0 110.841 168.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.11 -153.16 52.86 Favored Glycine 0 N--CA 1.448 -0.546 0 O-C-N 121.098 -1.001 . . . . 0.0 111.84 -170.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.03 166.92 23.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.83 -87.91 0.2 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 125.769 1.652 . . . . 0.0 110.804 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -76.42 168.27 29.49 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 124.889 1.275 . . . . 0.0 109.816 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -67.93 151.66 77.78 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 CA-C-N 121.379 1.528 . . . . 0.0 112.828 161.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -82.41 122.53 28.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.037 -1.039 . . . . 0.0 110.211 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 m -59.19 -12.37 5.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mt -120.23 140.26 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.55 98.22 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.96 1.704 . . . . 0.0 110.293 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -151.29 -67.48 0.18 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.417 -0.802 . . . . 0.0 110.061 -168.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -142.54 162.22 36.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.323 2.649 . . . . 0.0 109.214 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -54.7 -35.83 64.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.583 1.553 . . . . 0.0 114.454 -168.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -136.25 174.55 10.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.096 2.159 . . . . 0.0 111.811 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.66 162.09 39.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.195 -1.566 . . . . 0.0 109.863 167.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -66.71 172.52 3.23 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.231 1.012 . . . . 0.0 111.354 163.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.45 -1.073 0 C-N-CA 124.715 3.61 . . . . 0.0 114.994 157.518 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.52 0 N-CA-C 118.052 1.981 . . . . 0.0 118.052 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.5 137.18 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.77 2.028 . . . . 0.0 110.971 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.34 -150.92 20.7 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.072 1.32 . . . . 0.0 116.162 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -145.36 151.47 38.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 119.478 1.639 . . . . 0.0 113.418 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.72 -114.69 0.8 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 126.779 2.133 . . . . 0.0 109.894 -165.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 160.72 78.09 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 127.861 2.464 . . . . 0.0 113.514 172.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.67 138.17 62.81 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 CA-C-N 121.057 1.413 . . . . 0.0 111.691 151.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.7 164.83 25.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.416 0.686 . . . . 0.0 111.871 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.8 m -77.32 -57.51 3.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.688 -0.633 . . . . 0.0 111.668 -169.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.8 mt -94.72 -63.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -166.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.23 130.34 42.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.178 1.391 . . . . 0.0 109.178 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.9 t -69.05 21.65 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -63.04 132.31 51.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.113 2.165 . . . . 0.0 111.346 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -62.14 -15.84 48.59 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.476 -1.726 . . . . 0.0 113.398 168.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.0 120.55 16.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 121.515 1.961 . . . . 0.0 113.186 -172.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.37 153.8 41.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.123 2.169 . . . . 0.0 113.644 162.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -72.42 134.1 82.57 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-O 117.385 -1.293 . . . . 0.0 111.856 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo . . . . . 0 N--CA 1.45 -1.072 0 C-N-CA 122.573 2.182 . . . . 0.0 110.08 175.905 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.439 0 CA-C-O 117.433 -1.76 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.34 6.3 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 119.093 1.447 . . . . 0.0 114.585 -170.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.71 -155.38 25.34 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 125.811 1.672 . . . . 0.0 109.486 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.96 150.56 39.04 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 120.694 2.247 . . . . 0.0 114.92 171.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.66 -125.35 2.97 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.999 1.761 . . . . 0.0 115.532 -170.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.43 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -59.53 164.97 4.59 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 128.216 2.606 . . . . 0.0 113.929 171.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 6' ' ' ARG . 63.1 Cg_endo -71.49 155.34 59.76 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.833 3.689 . . . . 0.0 110.511 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.72 136.85 56.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.838 -1.164 . . . . 0.0 112.381 -173.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.2 p -64.48 -31.28 72.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.876 1.671 . . . . 0.0 115.026 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.5 pt -132.23 -13.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.1 mt -105.9 159.08 16.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.589 -1.319 . . . . 0.0 110.676 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -82.9 65.11 7.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.562 -1.336 . . . . 0.0 109.455 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -137.34 159.84 40.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.393 1.477 . . . . 0.0 110.567 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -105.65 -9.44 17.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.565 1.166 . . . . 0.0 111.623 -166.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -128.17 118.23 23.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.724 1.147 . . . . 0.0 112.054 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.0 150.79 37.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 129.096 2.958 . . . . 0.0 112.308 164.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HE2' ' HD2' ' A' ' 18' ' ' PRO . 3.0 mmpt? -74.42 171.88 10.17 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 120.61 -1.306 . . . . 0.0 110.909 163.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.449 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 59.0 Cg_endo . . . . . 0 N--CA 1.449 -1.138 0 CA-C-N 120.766 1.309 . . . . 0.0 111.275 150.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 CA-C-O 118.687 -1.063 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.23 116.09 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 126.515 1.926 . . . . 0.0 110.824 -177.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.83 -146.03 24.01 Favored Glycine 0 CA--C 1.523 0.546 0 O-C-N 119.918 -1.738 . . . . 0.0 113.095 -168.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -145.28 166.73 24.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.516 1.526 . . . . 0.0 110.145 174.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.99 -86.67 0.23 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.942 1.258 . . . . 0.0 115.075 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -122.39 173.52 4.11 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 127.683 2.393 . . . . 0.0 111.52 -174.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -48.97 154.07 3.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 124.042 3.162 . . . . 0.0 117.625 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -107.87 128.58 54.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.571 1.548 . . . . 0.0 109.358 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 p -69.89 -52.25 26.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -171.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.7 mt -99.29 -65.5 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.532 0.733 . . . . 0.0 110.056 -173.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.61 118.9 7.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.604 -1.31 . . . . 0.0 113.788 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -72.68 77.72 1.1 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.626 2.371 . . . . 0.0 110.873 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.44 172.88 12.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.38 2.272 . . . . 0.0 108.12 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -59.08 -67.6 0.35 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.429 1.491 . . . . 0.0 113.627 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -136.7 170.66 15.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.068 2.147 . . . . 0.0 111.125 -172.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.36 171.12 14.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 129.99 3.316 . . . . 0.0 109.012 167.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -66.28 167.01 13.74 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 120.99 -1.069 . . . . 0.0 108.896 159.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo . . . . . 0 N--CA 1.449 -1.12 0 CA-C-N 121.554 1.591 . . . . 0.0 111.072 158.075 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 119.251 -0.75 . . . . 0.0 114.687 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.93 140.54 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 118.194 0.997 . . . . 0.0 109.997 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.98 -164.66 53.1 Favored Glycine 0 CA--C 1.523 0.55 0 O-C-N 120.595 -1.316 . . . . 0.0 113.445 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -142.15 165.31 27.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.521 -0.987 . . . . 0.0 112.413 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.48 -26.74 3.31 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 128.562 2.982 . . . . 0.0 114.196 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.431 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 9.3 ptm180 -150.51 174.53 3.44 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 127.035 2.134 . . . . 0.0 110.546 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 6' ' ' ARG . 60.2 Cg_endo -72.15 159.29 50.22 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.712 2.275 . . . . 0.0 111.161 169.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -84.56 154.47 22.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.952 1.701 . . . . 0.0 112.684 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.1 p -124.4 -2.78 7.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.861 2.064 . . . . 0.0 114.908 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.2 mt -123.72 -43.12 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.846 2.058 . . . . 0.0 110.16 -170.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.8 mt -112.33 154.07 26.26 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.595 1.158 . . . . 0.0 111.201 169.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.1 m -69.96 87.1 0.54 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.28 1.032 . . . . 0.0 108.866 172.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -143.03 152.52 41.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.465 1.106 . . . . 0.0 110.931 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -79.62 -11.19 59.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -133.38 134.54 43.84 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.096 2.158 . . . . 0.0 111.707 -170.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.19 163.13 36.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.478 1.111 . . . . 0.0 110.699 155.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -87.83 145.58 37.06 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 127.326 2.251 . . . . 0.0 110.198 155.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.449 -1.143 0 CA-C-N 121.443 1.551 . . . . 0.0 111.423 168.239 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.507 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.03 133.43 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 118.25 1.025 . . . . 0.0 111.216 163.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.72 -159.71 7.09 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 125.195 1.378 . . . . 0.0 115.584 -170.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -141.28 169.73 17.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.219 1.408 . . . . 0.0 113.006 173.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.23 -154.92 16.66 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 128.086 2.755 . . . . 0.0 111.629 -154.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -34.42 138.57 0.32 Allowed Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 128.3 2.64 . . . . 0.0 115.789 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.6 146.4 43.65 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.117 2.545 . . . . 0.0 115.664 -170.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -68.51 133.41 48.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.789 1.236 . . . . 0.0 111.333 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 m -118.41 16.09 13.85 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.407 1.483 . . . . 0.0 113.856 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.1 mt -118.31 -63.21 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 128.565 2.746 . . . . 0.0 108.16 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -87.27 166.63 14.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.279 1.832 . . . . 0.0 109.432 173.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -77.98 82.37 4.34 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.204 1.401 . . . . 0.0 110.586 161.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -142.41 144.04 32.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.794 1.238 . . . . 0.0 112.629 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.42 -6.82 59.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -146.25 137.87 24.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.544 -1.217 . . . . 0.0 109.731 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.03 165.67 33.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.461 1.504 . . . . 0.0 113.652 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -59.95 134.66 90.05 Favored Pre-proline 0 N--CA 1.449 -0.524 0 O-C-N 119.719 -1.863 . . . . 0.0 111.193 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 N--CA 1.45 -1.056 0 C-N-CA 122.574 2.183 . . . . 0.0 109.839 168.065 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.55 0 CA-C-O 122.344 0.969 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.21 136.26 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 O-C-N 119.655 -2.085 . . . . 0.0 112.554 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.11 -154.27 27.53 Favored Glycine 0 CA--C 1.522 0.504 0 O-C-N 120.54 -1.35 . . . . 0.0 114.735 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -145.59 168.66 20.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.173 -0.604 . . . . 0.0 110.929 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.18 -19.45 17.55 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 118.177 2.031 . . . . 0.0 118.177 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -139.48 171.09 8.54 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 126.978 2.111 . . . . 0.0 108.143 171.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.39 152.84 75.15 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 CA-C-N 122.768 2.024 . . . . 0.0 113.288 168.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -71.93 162.11 29.95 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.034 -1.666 . . . . 0.0 112.479 165.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -103.33 -21.22 13.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.221 2.208 . . . . 0.0 115.769 170.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.7 mt -135.77 118.67 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.845 1.658 . . . . 0.0 109.312 -159.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.4 tp 70.26 142.27 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 129.67 3.188 . . . . 0.0 111.77 -170.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 m -60.85 88.87 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.619 1.168 . . . . 0.0 112.212 171.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -134.66 171.82 13.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.726 2.411 . . . . 0.0 110.956 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -78.65 -158.17 0.13 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 118.204 -2.81 . . . . 0.0 111.185 170.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -48.83 158.82 0.29 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.738 2.415 . . . . 0.0 115.772 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.65 -178.53 5.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.765 2.826 . . . . 0.0 112.466 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -135.85 151.42 74.01 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 130.22 3.408 . . . . 0.0 108.623 168.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.449 -1.136 0 C-N-CA 122.079 1.853 . . . . 0.0 113.19 170.649 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.539 0 CA-C-O 122.056 0.809 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.61 80.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.169 2.588 . . . . 0.0 109.892 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 113.26 -135.92 13.0 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 127.689 2.566 . . . . 0.0 114.682 168.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -144.99 149.42 35.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.374 1.087 . . . . 0.0 109.615 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.75 -62.14 0.48 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 125.262 1.411 . . . . 0.0 114.565 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.98 156.71 68.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 112.424 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.43 136.53 74.97 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.162 1.908 . . . . 0.0 111.952 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -64.13 146.87 53.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.735 2.014 . . . . 0.0 110.597 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.2 m -112.02 -10.09 13.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 mt -73.49 -60.95 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 119.997 1.271 . . . . 0.0 110.776 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.6 mt -125.94 171.06 11.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.368 1.467 . . . . 0.0 111.103 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -74.87 83.5 2.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.464 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -124.45 123.1 39.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.281 1.832 . . . . 0.0 108.656 166.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -57.18 -21.92 36.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.78 1.632 . . . . 0.0 113.164 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -132.99 118.16 18.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.787 2.035 . . . . 0.0 110.23 -163.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.81 154.73 40.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.461 2.305 . . . . 0.0 110.311 168.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -66.41 158.25 78.88 Favored Pre-proline 0 N--CA 1.45 -0.451 0 O-C-N 120.897 -1.127 . . . . 0.0 111.897 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 N--CA 1.45 -1.045 0 C-N-CA 122.413 2.076 . . . . 0.0 110.367 145.213 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.491 0 N-CA-C 117.856 1.902 . . . . 0.0 117.856 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.5 p -141.03 135.97 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 120.778 -1.425 . . . . 0.0 112.529 174.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 61.02 -110.6 3.16 Favored Glycine 0 CA--C 1.522 0.5 0 O-C-N 120.095 -1.628 . . . . 0.0 115.544 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -136.39 150.79 48.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.153 2.181 . . . . 0.0 113.153 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.36 -145.2 13.39 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.526 1.536 . . . . 0.0 115.116 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -58.68 175.76 0.3 Allowed Pre-proline 0 N--CA 1.449 -0.486 1 C-N-CA 132.692 4.397 . . . . 0.0 115.143 173.077 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 6' ' ' ARG . 55.4 Cg_endo -74.02 106.67 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.232 3.288 . . . . 0.0 113.464 165.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -74.21 101.8 4.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.798 1.239 . . . . 0.0 109.751 174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 m -76.78 28.57 0.13 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.383 2.673 . . . . 0.0 113.865 -168.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.66 -60.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.697 2.399 . . . . 0.0 108.163 168.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.59 89.69 3.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.414 1.486 . . . . 0.0 109.796 170.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -81.67 67.97 7.84 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.56 1.144 . . . . 0.0 112.359 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -77.94 66.32 3.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 123.863 1.792 . . . . 0.0 112.071 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 46.59 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.346 3.059 . . . . 0.0 113.75 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -100.04 117.89 35.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.27 146.47 29.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.786 1.279 . . . . 0.0 113.378 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -75.92 147.11 80.26 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 128.392 2.677 . . . . 0.0 110.601 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo . . . . . 0 N--CA 1.45 -1.075 0 C-N-CA 121.653 1.569 . . . . 0.0 112.335 175.343 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.07 152.88 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.38 1.872 . . . . 0.0 110.027 150.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.1 -137.49 31.67 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 119.957 1.253 . . . . 0.0 113.489 173.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -140.47 146.09 37.77 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.346 1.858 . . . . 0.0 114.32 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.8 -86.49 0.14 Allowed Glycine 0 C--N 1.336 0.547 0 O-C-N 121.467 -0.771 . . . . 0.0 114.043 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 161.59 45.4 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 128.595 2.758 . . . . 0.0 112.542 -172.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.96 124.46 13.57 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 CA-C-N 122.514 1.933 . . . . 0.0 110.911 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -58.23 114.62 2.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.151 1.381 . . . . 0.0 113.781 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.0 m -63.01 -24.88 68.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.2 mt -85.21 -55.17 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 119.711 1.141 . . . . 0.0 108.709 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -138.09 112.62 8.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 116.831 -1.557 . . . . 0.0 108.412 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -65.0 77.03 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -162.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -75.48 139.51 42.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 112.693 -2.049 . . . . 0.0 112.649 159.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -70.24 121.68 18.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.85 0.833 . . . . 0.0 111.845 170.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 59.06 104.47 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.689 2.396 . . . . 0.0 115.782 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.15 146.41 42.74 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 129.334 3.054 . . . . 0.0 111.519 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -63.24 113.87 10.91 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 127.846 2.459 . . . . 0.0 110.179 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo . . . . . 0 N--CA 1.448 -1.151 0 C-N-CA 121.461 1.441 . . . . 0.0 111.618 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.475 0 N-CA-C 116.181 1.232 . . . . 0.0 116.181 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.46 100.02 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.69 1.996 . . . . 0.0 109.243 -170.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.87 -161.34 53.93 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -170.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.56 172.9 7.33 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.441 1.496 . . . . 0.0 112.563 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.34 -63.81 0.58 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 118.851 0.75 . . . . 0.0 114.086 175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -134.28 174.31 4.81 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 129.471 3.108 . . . . 0.0 111.205 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -66.0 147.98 85.2 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 CA-C-N 124.023 2.473 . . . . 0.0 114.023 174.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -70.94 134.18 47.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 120.683 -1.261 . . . . 0.0 108.783 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.5 m -75.52 -39.67 58.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 119.834 -1.791 . . . . 0.0 114.992 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 mt -83.92 -71.95 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 126.082 1.753 . . . . 0.0 110.989 -172.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -138.71 143.97 39.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 122.312 1.053 . . . . 0.0 110.432 -170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.5 70.18 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.039 2.535 . . . . 0.0 114.118 -171.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.36 154.29 38.92 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 132.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.31 -42.75 92.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.638 -2.538 . . . . 0.0 113.303 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -135.73 169.06 18.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.425 1.49 . . . . 0.0 114.525 -175.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.37 156.8 32.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 130.105 3.362 . . . . 0.0 111.622 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -69.83 157.58 89.33 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 125.931 1.692 . . . . 0.0 113.073 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.18 169.89 14.32 Favored 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 126.465 4.777 . . . . 0.0 110.381 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 76.5 mtp . . . . . 0 C--O 1.25 1.1 0 N-CA-C 115.916 1.821 . . . . 0.0 115.916 -169.785 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 CA-C-O 121.734 0.63 . . . . 0.0 111.675 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -143.92 118.89 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 125.336 1.454 . . . . 0.0 110.366 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 69.1 -162.38 51.57 Favored Glycine 0 C--N 1.335 0.509 0 CA-C-N 119.878 1.217 . . . . 0.0 111.562 -170.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -131.57 168.31 17.91 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 119.525 -2.162 . . . . 0.0 111.009 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.57 -77.43 0.31 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 127.163 2.316 . . . . 0.0 113.658 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.64 161.02 43.95 Favored Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 126.301 1.84 . . . . 0.0 114.798 -171.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.03 119.48 6.71 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 CA-C-N 120.634 1.262 . . . . 0.0 113.34 176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -54.07 117.64 3.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.261 2.224 . . . . 0.0 109.254 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.9 m -62.63 -9.6 9.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 116.741 2.126 . . . . 0.0 116.741 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.2 mt -137.48 -64.06 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 C-N-CA 125.917 1.687 . . . . 0.0 111.142 -170.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.5 mt -92.9 160.92 14.69 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.335 1.454 . . . . 0.0 113.815 -167.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -83.14 72.48 10.13 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.819 1.248 . . . . 0.0 113.7 -165.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -144.41 159.09 43.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.029 0.919 . . . . 0.0 111.395 167.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -61.47 -32.61 72.61 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 116.754 -1.593 . . . . 0.0 114.732 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -140.06 156.33 46.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 -176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.91 158.88 44.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.317 3.047 . . . . 0.0 111.581 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -96.9 140.97 22.41 Favored Pre-proline 0 N--CA 1.449 -0.477 0 C-N-CA 127.941 2.497 . . . . 0.0 110.561 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -58.19 148.74 76.7 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.322 2.015 . . . . 0.0 113.36 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 97.6 mtp . . . . . 0 C--O 1.25 1.107 0 CA-C-O 117.629 -1.177 . . . . 0.0 113.296 -160.785 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.767 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.0 p -148.15 155.9 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.137 2.175 . . . . 0.0 107.108 161.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 54.06 -139.39 37.26 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 121.636 2.016 . . . . 0.0 113.582 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.99 146.8 49.73 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.727 1.611 . . . . 0.0 113.618 175.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.43 -78.54 0.08 OUTLIER Glycine 0 C--N 1.335 0.497 0 N-CA-C 116.906 1.523 . . . . 0.0 116.906 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -145.68 172.67 5.03 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 129.633 3.173 . . . . 0.0 111.782 -168.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.08 100.68 0.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.309 2.006 . . . . 0.0 111.216 169.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' A' ' 16' ' ' ALA . 29.2 t0 -81.04 74.66 8.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.357 1.463 . . . . 0.0 110.329 173.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -56.5 -7.72 0.44 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -159.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.0 mt -52.57 -46.05 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 127.395 2.278 . . . . 0.0 111.531 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tt -134.79 139.48 45.15 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.357 1.863 . . . . 0.0 110.216 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 m -72.49 80.19 1.06 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.457 1.103 . . . . 0.0 111.317 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -137.54 165.48 26.2 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.614 1.166 . . . . 0.0 110.436 168.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.04 155.23 40.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.469 1.108 . . . . 0.0 112.668 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 29.21 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.16 3.784 . . . . 0.0 113.42 147.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 8' ' ' ASP . . . -136.25 146.63 46.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.59 2.356 . . . . 0.0 110.315 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -59.96 155.41 43.28 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 126.7 2.0 . . . . 0.0 112.421 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.8 163.78 8.75 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 123.154 2.57 . . . . 0.0 112.512 157.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 C--O 1.25 1.1 0 C-N-CA 123.732 0.813 . . . . 0.0 112.026 -164.914 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.504 0 CA-C-O 117.512 -1.715 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -152.59 152.49 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.848 2.059 . . . . 0.0 109.415 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.57 -160.99 43.36 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 119.183 0.901 . . . . 0.0 114.312 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.71 164.28 28.62 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.594 -1.533 . . . . 0.0 114.719 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.72 -154.76 19.34 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 124.735 1.159 . . . . 0.0 111.306 -158.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -50.51 150.32 4.89 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 126.876 2.07 . . . . 0.0 113.076 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.65 145.06 96.96 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 123.864 3.043 . . . . 0.0 113.788 -168.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -68.6 139.29 55.53 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 120.626 -1.296 . . . . 0.0 109.489 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.5 m -71.77 -79.36 0.07 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 66.7 mt -75.03 -74.99 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.609 1.164 . . . . 0.0 112.015 -173.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 tp -60.06 117.99 5.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.862 -1.774 . . . . 0.0 109.053 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -69.3 71.9 0.29 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.522 1.529 . . . . 0.0 112.984 -171.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -108.52 135.48 49.71 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.784 1.634 . . . . 0.0 107.705 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -56.16 -38.14 70.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.506 -1.371 . . . . 0.0 113.359 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -131.43 153.52 49.63 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.297 1.439 . . . . 0.0 108.508 178.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.82 153.15 42.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.471 1.908 . . . . 0.0 113.324 172.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -61.93 141.91 95.32 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.851 169.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.7 115.07 3.55 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.286 2.658 . . . . 0.0 110.085 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 62.4 mtm . . . . . 0 C--O 1.251 1.154 0 C-N-CA 127.536 2.334 . . . . 0.0 110.495 -178.04 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.47 112.26 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 127.237 2.215 . . . . 0.0 108.233 171.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.6 -163.38 27.27 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 126.6 2.048 . . . . 0.0 114.97 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -117.01 155.1 29.77 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.523 1.129 . . . . 0.0 112.106 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.472 ' H ' ' NE2' ' A' ' 15' ' ' GLN . . . 128.04 -137.18 9.59 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 127.187 2.327 . . . . 0.0 114.202 -169.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -63.1 150.89 87.64 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 128.071 2.549 . . . . 0.0 111.996 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -62.62 147.94 94.06 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 123.862 3.041 . . . . 0.0 112.985 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -96.82 87.01 4.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 114.231 -1.35 . . . . 0.0 113.052 -162.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.4 m -50.74 -30.22 13.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.2 mt -68.69 -26.51 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 125.425 1.49 . . . . 0.0 110.04 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.5 mt -131.77 -152.03 0.49 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.135 2.174 . . . . 0.0 108.169 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -130.48 89.83 2.83 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.508 -1.37 . . . . 0.0 110.694 160.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 -138.26 155.28 48.77 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.29 1.836 . . . . 0.0 110.361 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -56.58 -38.62 72.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.479 1.112 . . . . 0.0 113.782 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' NE2' ' H ' ' A' ' 5' ' ' GLY . 36.5 mt-30 -141.63 153.56 44.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.43 154.81 40.39 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 129.724 3.21 . . . . 0.0 110.802 157.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -76.06 151.49 83.98 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-O 116.662 -1.637 . . . . 0.0 108.454 159.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.2 162.37 30.18 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.078 2.519 . . . . 0.0 109.103 167.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.1 ptm . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.761 2.025 . . . . 0.0 115.311 -172.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 112.936 -0.065 . . . . 0.0 112.936 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 p -149.4 95.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 126.996 2.118 . . . . 0.0 113.603 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.07 -124.11 19.36 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 124.984 1.278 . . . . 0.0 112.034 -174.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.96 163.55 39.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.967 1.707 . . . . 0.0 114.023 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.37 -52.19 0.49 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 128.005 2.716 . . . . 0.0 113.114 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -139.88 175.39 3.23 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 131.421 3.888 . . . . 0.0 109.626 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -70.79 163.71 38.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 CA-C-N 124.869 2.775 . . . . 0.0 112.896 175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -78.3 99.98 6.53 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 171.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.4 m -65.12 -15.36 62.31 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.49 -46.0 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.403 1.081 . . . . 0.0 112.616 179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 tt -153.64 114.77 4.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 126.797 2.039 . . . . 0.0 109.707 173.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.7 m -63.9 109.2 1.69 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.002 0.921 . . . . 0.0 112.03 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -134.0 -81.46 0.46 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 165.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -123.13 -174.46 2.95 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.739 2.416 . . . . 0.0 111.146 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -66.28 166.07 12.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 114.774 1.398 . . . . 0.0 114.774 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.45 178.95 9.72 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 128.494 2.718 . . . . 0.0 111.921 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -105.32 170.01 6.42 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 126.944 2.098 . . . . 0.0 111.6 161.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -77.67 -175.02 2.46 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 122.967 2.445 . . . . 0.0 111.973 167.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 48.6 ttp . . . . . 0 C--O 1.251 1.159 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.538 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 117.524 -1.709 . . . . 0.0 114.298 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 p -116.93 129.3 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 120.239 2.019 . . . . 0.0 110.453 174.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.87 -155.75 39.33 Favored Glycine 0 C--N 1.335 0.52 0 O-C-N 120.799 -1.188 . . . . 0.0 113.214 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.269 0.3 OUTLIER -134.38 165.53 24.93 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 120.369 -1.665 . . . . 0.0 113.638 175.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.37 -153.19 17.59 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 126.166 1.841 . . . . 0.0 110.961 -159.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.22 148.46 3.16 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 127.205 2.202 . . . . 0.0 114.703 -175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -68.77 149.05 72.63 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.854 3.036 . . . . 0.0 111.986 -174.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -93.05 160.31 14.92 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 119.517 -1.989 . . . . 0.0 113.839 -160.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.0 m -97.95 -32.2 11.79 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 -161.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -116.53 -69.25 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 125.215 1.406 . . . . 0.0 110.187 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 11' ' ' LEU . 2.4 mm? -66.88 119.65 12.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.849 1.259 . . . . 0.0 109.842 177.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.9 m -47.91 108.53 0.17 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.633 1.573 . . . . 0.0 112.073 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -156.48 144.38 19.47 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.638 -1.289 . . . . 0.0 113.855 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.44 -31.89 73.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 165.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -144.12 149.69 36.93 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 125.192 1.558 . . . . 0.0 113.882 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.7 161.78 34.92 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.086 2.555 . . . . 0.0 112.138 171.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 17' ' ' LYS . 7.1 mmpt? -58.33 145.91 73.3 Favored Pre-proline 0 N--CA 1.449 -0.486 0 O-C-N 120.524 -1.36 . . . . 0.0 113.186 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.28 134.14 28.23 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 N-CA-C 108.982 -1.199 . . . . 0.0 108.982 160.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.9 ttm . . . . . 0 C--O 1.25 1.122 0 C-N-CA 125.699 1.599 . . . . 0.0 112.67 -170.329 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 CA-C-O 118.442 -1.199 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.15 141.1 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 120.458 2.129 . . . . 0.0 111.325 159.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.22 -165.4 54.61 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 119.147 0.885 . . . . 0.0 112.981 -165.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -136.16 142.43 44.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.299 -1.118 . . . . 0.0 111.601 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.9 -113.16 0.55 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 126.156 1.836 . . . . 0.0 110.663 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 43.9 ptt85 -64.9 168.84 6.33 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-N 120.687 2.244 . . . . 0.0 112.719 168.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.82 161.38 39.5 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 CA-C-N 120.725 1.295 . . . . 0.0 113.523 163.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -76.62 158.78 30.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 119.42 -2.05 . . . . 0.0 112.029 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.8 m -83.94 -28.03 28.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.874 2.47 . . . . 0.0 114.377 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.7 mt -107.54 -79.95 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 125.564 1.546 . . . . 0.0 111.107 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.96 137.95 16.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.274 1.829 . . . . 0.0 109.701 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.283 12.4 t -71.61 74.44 0.8 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.235 1.014 . . . . 0.0 109.576 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -139.52 150.29 44.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 119.377 -2.077 . . . . 0.0 112.257 -166.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -86.37 -18.36 32.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.113 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -129.3 116.53 19.25 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.181 1.392 . . . . 0.0 112.872 -166.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.84 127.82 15.52 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.567 2.347 . . . . 0.0 109.659 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -77.43 124.88 86.82 Favored Pre-proline 0 N--CA 1.449 -0.505 0 O-C-N 119.281 -2.137 . . . . 0.0 108.269 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -60.82 165.48 11.82 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.469 2.78 . . . . 0.0 115.802 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 C--O 1.25 1.096 0 CA-C-O 116.254 -1.831 . . . . 0.0 111.143 -170.086 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.529 0 CA-C-O 119.534 -0.592 . . . . 0.0 112.84 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 m -149.61 65.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.741 1.216 . . . . 0.0 110.441 -162.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 73.99 177.86 37.05 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 127.895 2.664 . . . . 0.0 114.927 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -64.22 141.73 58.67 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 119.969 -1.901 . . . . 0.0 115.015 -169.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.93 -144.02 11.28 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 125.391 1.472 . . . . 0.0 112.792 -173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.35 164.88 12.82 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 125.765 1.626 . . . . 0.0 113.696 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -60.45 135.77 63.36 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 CA-C-N 122.759 2.021 . . . . 0.0 111.509 166.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -88.21 93.09 9.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.879 0.847 . . . . 0.0 110.886 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -67.81 -22.69 65.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.3 mt -79.66 -49.41 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.28 1.032 . . . . 0.0 112.931 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -132.4 116.5 16.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.824 1.649 . . . . 0.0 108.097 -174.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.8 m -48.78 95.63 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.577 2.351 . . . . 0.0 115.576 -166.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -150.83 163.85 37.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 129.367 3.067 . . . . 0.0 109.363 160.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -85.03 10.87 10.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.544 -1.348 . . . . 0.0 114.574 166.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -144.72 122.95 12.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.378 1.871 . . . . 0.0 114.175 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.43 133.43 25.83 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.907 2.883 . . . . 0.0 112.068 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -46.2 115.64 3.14 Favored Pre-proline 0 N--CA 1.448 -0.529 0 C-N-CA 126.472 1.909 . . . . 0.0 110.577 169.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -64.91 119.95 7.09 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 124.418 3.412 . . . . 0.0 111.278 -166.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.2 ttp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 128.389 2.676 . . . . 0.0 111.327 177.399 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 117.623 1.809 . . . . 0.0 117.623 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.53 169.73 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 126.984 2.114 . . . . 0.0 108.36 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.84 -143.54 45.17 Favored Glycine 0 CA--C 1.522 0.511 0 O-C-N 119.61 -1.932 . . . . 0.0 113.594 161.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -141.7 161.05 38.9 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.414 1.086 . . . . 0.0 113.417 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.14 -78.18 0.21 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 126.469 1.985 . . . . 0.0 112.97 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.71 167.14 23.41 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 130.253 3.421 . . . . 0.0 114.025 -167.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -70.73 113.09 3.42 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 CA-C-N 122.908 2.074 . . . . 0.0 115.523 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -68.63 105.39 2.25 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.371 1.468 . . . . 0.0 110.448 163.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 m -58.04 -19.11 28.95 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 117.678 2.473 . . . . 0.0 117.678 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.9 mm -94.98 -16.74 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.574 1.95 . . . . 0.0 108.821 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.2 tp -146.63 93.45 2.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 119.825 -1.797 . . . . 0.0 112.028 -168.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.0 p -64.23 16.25 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 119.563 3.172 . . . . 0.0 119.563 -172.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -52.98 104.87 0.1 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.025 0.93 . . . . 0.0 111.361 159.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -67.4 138.17 56.49 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 124.149 0.906 . . . . 0.0 111.518 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.49 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.503 1.921 . . . . 0.0 112.223 -157.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.1 -170.14 2.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.258 1.823 . . . . 0.0 111.667 170.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -148.27 135.74 10.73 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 126.85 2.06 . . . . 0.0 108.342 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -62.57 172.46 4.48 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.373 2.049 . . . . 0.0 110.195 171.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 C--O 1.25 1.086 0 CA-C-N 113.64 -1.618 . . . . 0.0 114.768 -177.109 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.527 0 CA-C-O 118.184 -1.342 . . . . 0.0 112.839 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.46 114.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 128.996 2.919 . . . . 0.0 110.841 168.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.11 -153.16 52.86 Favored Glycine 0 N--CA 1.448 -0.546 0 O-C-N 121.098 -1.001 . . . . 0.0 111.84 -170.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -143.03 166.92 23.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.83 -87.91 0.2 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 125.769 1.652 . . . . 0.0 110.804 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -76.42 168.27 29.49 Favored Pre-proline 0 N--CA 1.449 -0.491 0 C-N-CA 124.889 1.275 . . . . 0.0 109.816 171.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -67.93 151.66 77.78 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 CA-C-N 121.379 1.528 . . . . 0.0 112.828 161.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -82.41 122.53 28.12 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 121.037 -1.039 . . . . 0.0 110.211 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 m -59.19 -12.37 5.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mt -120.23 140.26 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.55 98.22 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.96 1.704 . . . . 0.0 110.293 169.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.1 m -151.29 -67.48 0.18 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.417 -0.802 . . . . 0.0 110.061 -168.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -142.54 162.22 36.03 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.323 2.649 . . . . 0.0 109.214 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -54.7 -35.83 64.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.583 1.553 . . . . 0.0 114.454 -168.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -136.25 174.55 10.49 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.096 2.159 . . . . 0.0 111.811 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.66 162.09 39.18 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.195 -1.566 . . . . 0.0 109.863 167.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -66.71 172.52 3.23 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.231 1.012 . . . . 0.0 111.354 163.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.9 171.74 0.97 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 124.715 3.61 . . . . 0.0 114.994 157.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 17.2 ttt . . . . . 0 C--O 1.249 1.064 0 C-N-CA 127.36 2.264 . . . . 0.0 113.374 178.836 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.52 0 N-CA-C 118.052 1.981 . . . . 0.0 118.052 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.5 137.18 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.77 2.028 . . . . 0.0 110.971 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.34 -150.92 20.7 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.072 1.32 . . . . 0.0 116.162 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -145.36 151.47 38.33 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 119.478 1.639 . . . . 0.0 113.418 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.72 -114.69 0.8 Allowed Glycine 0 CA--C 1.522 0.48 0 C-N-CA 126.779 2.133 . . . . 0.0 109.894 -165.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 160.72 78.09 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 127.861 2.464 . . . . 0.0 113.514 172.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.67 138.17 62.81 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 CA-C-N 121.057 1.413 . . . . 0.0 111.691 151.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.7 164.83 25.9 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.416 0.686 . . . . 0.0 111.871 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.8 m -77.32 -57.51 3.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 O-C-N 121.688 -0.633 . . . . 0.0 111.668 -169.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.8 mt -94.72 -63.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -166.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.23 130.34 42.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.178 1.391 . . . . 0.0 109.178 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.9 t -69.05 21.65 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -63.04 132.31 51.53 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.113 2.165 . . . . 0.0 111.346 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -62.14 -15.84 48.59 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.476 -1.726 . . . . 0.0 113.398 168.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.0 120.55 16.12 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 121.515 1.961 . . . . 0.0 113.186 -172.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.37 153.8 41.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 127.123 2.169 . . . . 0.0 113.644 162.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -72.42 134.1 82.57 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-O 117.385 -1.293 . . . . 0.0 111.856 173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.7 88.48 1.04 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.573 2.182 . . . . 0.0 110.08 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 40.6 mmm . . . . . 0 C--O 1.25 1.117 0 C-N-CA 129.953 3.301 . . . . 0.0 115.161 178.173 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.439 0 CA-C-O 117.433 -1.76 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.34 6.3 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 119.093 1.447 . . . . 0.0 114.585 -170.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.71 -155.38 25.34 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 125.811 1.672 . . . . 0.0 109.486 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.96 150.56 39.04 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 120.694 2.247 . . . . 0.0 114.92 171.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.66 -125.35 2.97 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.999 1.761 . . . . 0.0 115.532 -170.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.43 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -59.53 164.97 4.59 Favored Pre-proline 0 N--CA 1.449 -0.511 0 C-N-CA 128.216 2.606 . . . . 0.0 113.929 171.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 6' ' ' ARG . 63.1 Cg_endo -71.49 155.34 59.76 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 124.833 3.689 . . . . 0.0 110.511 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.72 136.85 56.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.838 -1.164 . . . . 0.0 112.381 -173.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.2 p -64.48 -31.28 72.43 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.876 1.671 . . . . 0.0 115.026 -173.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.5 pt -132.23 -13.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.1 mt -105.9 159.08 16.3 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.589 -1.319 . . . . 0.0 110.676 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.7 m -82.9 65.11 7.86 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 120.562 -1.336 . . . . 0.0 109.455 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -137.34 159.84 40.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.393 1.477 . . . . 0.0 110.567 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -105.65 -9.44 17.35 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.565 1.166 . . . . 0.0 111.623 -166.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -128.17 118.23 23.0 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.724 1.147 . . . . 0.0 112.054 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.0 150.79 37.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 129.096 2.958 . . . . 0.0 112.308 164.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.449 ' HE2' ' HD2' ' A' ' 18' ' ' PRO . 3.0 mmpt? -74.42 171.88 10.17 Favored Pre-proline 0 N--CA 1.448 -0.533 0 O-C-N 120.61 -1.306 . . . . 0.0 110.909 163.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.449 ' HD2' ' HE2' ' A' ' 17' ' ' LYS . 59.0 Cg_endo -62.36 151.72 81.01 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 CA-C-N 120.766 1.309 . . . . 0.0 111.275 150.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.2 ttt . . . . . 0 C--O 1.25 1.13 0 C-N-CA 125.064 1.346 . . . . 0.0 112.467 177.298 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.488 0 CA-C-O 118.687 -1.063 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 p -148.23 116.09 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 126.515 1.926 . . . . 0.0 110.824 -177.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.83 -146.03 24.01 Favored Glycine 0 CA--C 1.523 0.546 0 O-C-N 119.918 -1.738 . . . . 0.0 113.095 -168.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -145.28 166.73 24.67 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.516 1.526 . . . . 0.0 110.145 174.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.99 -86.67 0.23 Allowed Glycine 0 C--N 1.335 0.495 0 C-N-CA 124.942 1.258 . . . . 0.0 115.075 -178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -122.39 173.52 4.11 Favored Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 127.683 2.393 . . . . 0.0 111.52 -174.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -48.97 154.07 3.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 124.042 3.162 . . . . 0.0 117.625 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -107.87 128.58 54.74 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.571 1.548 . . . . 0.0 109.358 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 p -69.89 -52.25 26.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -171.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.7 mt -99.29 -65.5 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 123.532 0.733 . . . . 0.0 110.056 -173.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.61 118.9 7.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 120.604 -1.31 . . . . 0.0 113.788 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 m -72.68 77.72 1.1 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.626 2.371 . . . . 0.0 110.873 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.44 172.88 12.24 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.38 2.272 . . . . 0.0 108.12 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -59.08 -67.6 0.35 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.429 1.491 . . . . 0.0 113.627 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.4 mm-40 -136.7 170.66 15.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.068 2.147 . . . . 0.0 111.125 -172.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.36 171.12 14.78 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 129.99 3.316 . . . . 0.0 109.012 167.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -66.28 167.01 13.74 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 120.99 -1.069 . . . . 0.0 108.896 159.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -59.32 148.76 84.9 Favored 'Trans proline' 0 N--CA 1.449 -1.12 0 CA-C-N 121.554 1.591 . . . . 0.0 111.072 158.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 53.2 mtm . . . . . 0 C--O 1.25 1.126 0 C-N-CA 125.93 1.692 . . . . 0.0 112.529 -163.263 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 119.251 -0.75 . . . . 0.0 114.687 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.93 140.54 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 118.194 0.997 . . . . 0.0 109.997 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.98 -164.66 53.1 Favored Glycine 0 CA--C 1.523 0.55 0 O-C-N 120.595 -1.316 . . . . 0.0 113.445 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -142.15 165.31 27.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 121.521 -0.987 . . . . 0.0 112.413 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.48 -26.74 3.31 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 128.562 2.982 . . . . 0.0 114.196 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.431 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 9.3 ptm180 -150.51 174.53 3.44 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 127.035 2.134 . . . . 0.0 110.546 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 6' ' ' ARG . 60.2 Cg_endo -72.15 159.29 50.22 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.712 2.275 . . . . 0.0 111.161 169.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -84.56 154.47 22.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.952 1.701 . . . . 0.0 112.684 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.1 p -124.4 -2.78 7.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.861 2.064 . . . . 0.0 114.908 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.2 mt -123.72 -43.12 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 126.846 2.058 . . . . 0.0 110.16 -170.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.8 mt -112.33 154.07 26.26 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.595 1.158 . . . . 0.0 111.201 169.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.1 m -69.96 87.1 0.54 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.28 1.032 . . . . 0.0 108.866 172.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -143.03 152.52 41.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.465 1.106 . . . . 0.0 110.931 -177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -79.62 -11.19 59.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -133.38 134.54 43.84 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.096 2.158 . . . . 0.0 111.707 -170.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.19 163.13 36.38 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.478 1.111 . . . . 0.0 110.699 155.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -87.83 145.58 37.06 Favored Pre-proline 0 N--CA 1.449 -0.49 0 C-N-CA 127.326 2.251 . . . . 0.0 110.198 155.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.05 159.96 32.12 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 CA-C-N 121.443 1.551 . . . . 0.0 111.423 168.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.6 ttt . . . . . 0 C--O 1.25 1.11 0 C-N-CA 124.772 1.229 . . . . 0.0 111.325 163.71 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.507 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p -63.03 133.43 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 118.25 1.025 . . . . 0.0 111.216 163.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 55.72 -159.71 7.09 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 125.195 1.378 . . . . 0.0 115.584 -170.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -141.28 169.73 17.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.219 1.408 . . . . 0.0 113.006 173.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 115.23 -154.92 16.66 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 128.086 2.755 . . . . 0.0 111.629 -154.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -34.42 138.57 0.32 Allowed Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 128.3 2.64 . . . . 0.0 115.789 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -53.6 146.4 43.65 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 123.117 2.545 . . . . 0.0 115.664 -170.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -68.51 133.41 48.53 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.789 1.236 . . . . 0.0 111.333 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.0 m -118.41 16.09 13.85 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.407 1.483 . . . . 0.0 113.856 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.1 mt -118.31 -63.21 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 128.565 2.746 . . . . 0.0 108.16 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 67.8 mt -87.27 166.63 14.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.279 1.832 . . . . 0.0 109.432 173.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -77.98 82.37 4.34 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.204 1.401 . . . . 0.0 110.586 161.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -142.41 144.04 32.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.794 1.238 . . . . 0.0 112.629 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.42 -6.82 59.53 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -173.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -146.25 137.87 24.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.544 -1.217 . . . . 0.0 109.731 -176.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.03 165.67 33.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.461 1.504 . . . . 0.0 113.652 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -59.95 134.66 90.05 Favored Pre-proline 0 N--CA 1.449 -0.524 0 O-C-N 119.719 -1.863 . . . . 0.0 111.193 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -66.15 143.5 71.66 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.574 2.183 . . . . 0.0 109.839 168.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 56.5 ttm . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.382 1.473 . . . . 0.0 111.33 -178.224 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.55 0 CA-C-O 122.344 0.969 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.21 136.26 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 O-C-N 119.655 -2.085 . . . . 0.0 112.554 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.11 -154.27 27.53 Favored Glycine 0 CA--C 1.522 0.504 0 O-C-N 120.54 -1.35 . . . . 0.0 114.735 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -145.59 168.66 20.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.173 -0.604 . . . . 0.0 110.929 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.18 -19.45 17.55 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 118.177 2.031 . . . . 0.0 118.177 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.1 ptm85 -139.48 171.09 8.54 Favored Pre-proline 0 N--CA 1.449 -0.487 0 C-N-CA 126.978 2.111 . . . . 0.0 108.143 171.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.39 152.84 75.15 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 CA-C-N 122.768 2.024 . . . . 0.0 113.288 168.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -71.93 162.11 29.95 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.034 -1.666 . . . . 0.0 112.479 165.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -103.33 -21.22 13.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.221 2.208 . . . . 0.0 115.769 170.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.7 mt -135.77 118.67 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.845 1.658 . . . . 0.0 109.312 -159.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.4 tp 70.26 142.27 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 129.67 3.188 . . . . 0.0 111.77 -170.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 m -60.85 88.87 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.619 1.168 . . . . 0.0 112.212 171.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -134.66 171.82 13.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 127.726 2.411 . . . . 0.0 110.956 -176.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -78.65 -158.17 0.13 Allowed 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 118.204 -2.81 . . . . 0.0 111.185 170.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -48.83 158.82 0.29 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.738 2.415 . . . . 0.0 115.772 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.65 -178.53 5.83 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 128.765 2.826 . . . . 0.0 112.466 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -135.85 151.42 74.01 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 130.22 3.408 . . . . 0.0 108.623 168.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -63.75 174.46 3.72 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.079 1.853 . . . . 0.0 113.19 170.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.7 ptm . . . . . 0 C--O 1.25 1.12 0 C-N-CA 127.578 2.351 . . . . 0.0 116.678 179.544 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.539 0 CA-C-O 122.056 0.809 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.61 80.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.169 2.588 . . . . 0.0 109.892 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 113.26 -135.92 13.0 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 127.689 2.566 . . . . 0.0 114.682 168.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -144.99 149.42 35.13 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 118.374 1.087 . . . . 0.0 109.615 -178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.75 -62.14 0.48 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 125.262 1.411 . . . . 0.0 114.565 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.98 156.71 68.34 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.963 1.705 . . . . 0.0 112.424 178.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.43 136.53 74.97 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.162 1.908 . . . . 0.0 111.952 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -64.13 146.87 53.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.735 2.014 . . . . 0.0 110.597 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 70.2 m -112.02 -10.09 13.95 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 mt -73.49 -60.95 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 119.997 1.271 . . . . 0.0 110.776 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.6 mt -125.94 171.06 11.06 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.368 1.467 . . . . 0.0 111.103 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -74.87 83.5 2.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.464 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -124.45 123.1 39.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.281 1.832 . . . . 0.0 108.656 166.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -57.18 -21.92 36.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.78 1.632 . . . . 0.0 113.164 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -132.99 118.16 18.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.787 2.035 . . . . 0.0 110.23 -163.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.81 154.73 40.86 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.461 2.305 . . . . 0.0 110.311 168.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -66.41 158.25 78.88 Favored Pre-proline 0 N--CA 1.45 -0.451 0 O-C-N 120.897 -1.127 . . . . 0.0 111.897 169.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.65 101.96 0.06 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.413 2.076 . . . . 0.0 110.367 145.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 30.7 tpp . . . . . 0 C--O 1.25 1.118 0 C-N-CA 127.859 2.464 . . . . 0.0 112.15 -169.311 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.491 0 N-CA-C 117.856 1.902 . . . . 0.0 117.856 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.5 p -141.03 135.97 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 O-C-N 120.778 -1.425 . . . . 0.0 112.529 174.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 61.02 -110.6 3.16 Favored Glycine 0 CA--C 1.522 0.5 0 O-C-N 120.095 -1.628 . . . . 0.0 115.544 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -136.39 150.79 48.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 127.153 2.181 . . . . 0.0 113.153 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.36 -145.2 13.39 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.526 1.536 . . . . 0.0 115.116 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -58.68 175.76 0.3 Allowed Pre-proline 0 N--CA 1.449 -0.486 1 C-N-CA 132.692 4.397 . . . . 0.0 115.143 173.077 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 6' ' ' ARG . 55.4 Cg_endo -74.02 106.67 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 124.232 3.288 . . . . 0.0 113.464 165.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -74.21 101.8 4.09 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.798 1.239 . . . . 0.0 109.751 174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 m -76.78 28.57 0.13 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 128.383 2.673 . . . . 0.0 113.865 -168.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -125.66 -60.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 127.697 2.399 . . . . 0.0 108.163 168.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.59 89.69 3.17 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.414 1.486 . . . . 0.0 109.796 170.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -81.67 67.97 7.84 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.56 1.144 . . . . 0.0 112.359 -173.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -77.94 66.32 3.56 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 123.863 1.792 . . . . 0.0 112.071 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 46.59 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.346 3.059 . . . . 0.0 113.75 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -100.04 117.89 35.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.27 146.47 29.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.786 1.279 . . . . 0.0 113.378 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -75.92 147.11 80.26 Favored Pre-proline 0 N--CA 1.448 -0.545 0 C-N-CA 128.392 2.677 . . . . 0.0 110.601 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -66.25 143.03 69.19 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 121.653 1.569 . . . . 0.0 112.335 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 71.1 mmm . . . . . 0 C--O 1.25 1.107 0 C-N-CA 126.283 1.833 . . . . 0.0 112.666 173.918 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 N-CA-C 114.091 0.396 . . . . 0.0 114.091 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.07 152.88 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.38 1.872 . . . . 0.0 110.027 150.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 68.1 -137.49 31.67 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 119.957 1.253 . . . . 0.0 113.489 173.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -140.47 146.09 37.77 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.346 1.858 . . . . 0.0 114.32 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.8 -86.49 0.14 Allowed Glycine 0 C--N 1.336 0.547 0 O-C-N 121.467 -0.771 . . . . 0.0 114.043 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 161.59 45.4 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 128.595 2.758 . . . . 0.0 112.542 -172.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -63.96 124.46 13.57 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 CA-C-N 122.514 1.933 . . . . 0.0 110.911 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -58.23 114.62 2.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.151 1.381 . . . . 0.0 113.781 -171.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.0 m -63.01 -24.88 68.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.2 mt -85.21 -55.17 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 119.711 1.141 . . . . 0.0 108.709 -175.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -138.09 112.62 8.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 116.831 -1.557 . . . . 0.0 108.412 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 m -65.0 77.03 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 -162.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -75.48 139.51 42.27 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 112.693 -2.049 . . . . 0.0 112.649 159.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -70.24 121.68 18.05 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.85 0.833 . . . . 0.0 111.845 170.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 59.06 104.47 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 127.689 2.396 . . . . 0.0 115.782 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.15 146.41 42.74 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 129.334 3.054 . . . . 0.0 111.519 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -63.24 113.87 10.91 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 127.846 2.459 . . . . 0.0 110.179 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.99 153.75 76.75 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.461 1.441 . . . . 0.0 111.618 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 40.0 ttm . . . . . 0 C--O 1.25 1.104 0 C-N-CA 126.185 1.794 . . . . 0.0 112.761 175.634 . . . . . . . . 0 0 . 1 stop_ save_